e10vq
UNITED STATES SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C.
20549
Form 10-Q
|
|
|
(Mark One)
|
|
|
þ
|
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
|
|
|
For the quarterly period ended
March 31, 2006
|
OR
|
o
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
|
Commission file number: 1-32381
HERBALIFE LTD.
(Exact name of registrant as
specified in its charter)
|
|
|
Cayman Islands
|
|
98-0377871
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification No.)
|
P.O. Box 309GT
Ugland House, South Church Street
Grand Cayman, Cayman Islands
(Address of principal executive
offices) (Zip code)
(310) 410-9600*
(Registrants telephone
number, including area code)
Indicate by check mark whether the registrant (1) has filed
all reports required to be filed by Section 13 or 15(d) of
the Securities Exchange Act of 1934 during the preceding
12 months (or for such shorter period that the registrant
was required to file such reports), and (2) has been
subject to such filing requirements for the past
90 days. Yes þ No o
Indicate by check mark whether the registrant is a large
accelerated filer, an accelerated filer, or a non-accelerated
filer. See definition of accelerated filer and large
accelerated filer in
Rule 12b-2
of the Exchange Act. (Check one):
Large accelerated
filer o
Accelerated
filer þ Non-accelerated
filer o
Indicate by check mark whether the registrant is a shell company
(as defined in
Rule 12b-2
of the Exchange
Act). Yes o No þ
Number of shares of registrants common shares outstanding
as of April 27, 2006 was 70,197,359.
|
|
|
* |
|
C/O Chief Financial Officer of Herbalife International, Inc. |
HERBALIFE
LTD.
Index to Financial Statements and Exhibits
Filed with the Quarterly Report of the Company on
Form 10-Q
For the Three Months ended March 31, 2006
2
PART I.
FINANCIAL INFORMATION
|
|
Item 1.
|
FINANCIAL
STATEMENTS
|
HERBALIFE
LTD.
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
March 31,
|
|
|
|
2005
|
|
|
2006
|
|
|
|
|
|
|
(Unaudited)
|
|
|
|
(In thousands, except share
amounts)
|
|
|
ASSETS
|
CURRENT ASSETS:
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
88,248
|
|
|
$
|
109,221
|
|
Receivables, net of allowance for
doubtful accounts of $4,678 (2005) and $5,218 (2006)
|
|
|
37,266
|
|
|
|
45,829
|
|
Inventories
|
|
|
109,785
|
|
|
|
106,042
|
|
Prepaid expenses and other current
assets
|
|
|
40,667
|
|
|
|
51,579
|
|
Deferred income taxes
|
|
|
23,585
|
|
|
|
21,935
|
|
|
|
|
|
|
|
|
|
|
Total current assets
|
|
|
299,551
|
|
|
|
334,606
|
|
|
|
|
|
|
|
|
|
|
Property, at cost, net of
accumulated depreciation and amortization of $30,819 (2005) and
$36,996 (2006)
|
|
|
64,946
|
|
|
|
70,853
|
|
Deferred compensation plan assets
|
|
|
13,149
|
|
|
|
15,772
|
|
Other assets
|
|
|
7,510
|
|
|
|
10,122
|
|
Deferred financing costs, net of
accumulated amortization of $3,749 (2005) and $4,084 (2006)
|
|
|
3,531
|
|
|
|
3,196
|
|
Marketing related intangibles
|
|
|
310,000
|
|
|
|
310,000
|
|
Product certification, product
formulae and other intangible assets, net of accumulated
amortization of $17,792 (2005) and $18,567 (2006)
|
|
|
4,908
|
|
|
|
4,133
|
|
Goodwill
|
|
|
134,206
|
|
|
|
129,484
|
|
|
|
|
|
|
|
|
|
|
TOTAL
|
|
$
|
837,801
|
|
|
$
|
878,166
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND
SHAREHOLDERS EQUITY
|
CURRENT LIABILITIES:
|
|
|
|
|
|
|
|
|
Accounts payable
|
|
$
|
39,156
|
|
|
$
|
32,509
|
|
Royalty overrides
|
|
|
87,401
|
|
|
|
90,495
|
|
Accrued compensation
|
|
|
32,570
|
|
|
|
28,580
|
|
Accrued expenses
|
|
|
93,597
|
|
|
|
102,251
|
|
Current portion of long term debt
|
|
|
9,816
|
|
|
|
8,512
|
|
Advance sales deposits
|
|
|
10,874
|
|
|
|
16,964
|
|
Income taxes payable
|
|
|
12,043
|
|
|
|
12,129
|
|
|
|
|
|
|
|
|
|
|
Total current liabilities
|
|
|
285,457
|
|
|
|
291,440
|
|
NON-CURRENT LIABILITIES:
|
|
|
|
|
|
|
|
|
Long term debt, net of current
portion
|
|
|
253,276
|
|
|
|
242,531
|
|
Deferred compensation
|
|
|
15,145
|
|
|
|
15,675
|
|
Deferred income taxes
|
|
|
112,714
|
|
|
|
112,989
|
|
Other non-current liabilities
|
|
|
2,321
|
|
|
|
3,253
|
|
|
|
|
|
|
|
|
|
|
Total liabilities
|
|
|
668,913
|
|
|
|
665,888
|
|
|
|
|
|
|
|
|
|
|
COMMITMENTS AND CONTINGENCIES
|
|
|
|
|
|
|
|
|
SHAREHOLDERS EQUITY:
|
|
|
|
|
|
|
|
|
Preference shares, $0.002 par
value, 7.5 million shares authorized and unissued
|
|
|
|
|
|
|
|
|
Common shares, $0.002 par
value, 175 million shares authorized, 69.9 million
(2005) and 70.0 million (2006) shares issued and
outstanding
|
|
|
140
|
|
|
|
140
|
|
Treasury shares, at cost
|
|
|
(210
|
)
|
|
|
(210
|
)
|
Paid-in-capital
in excess of par value
|
|
|
89,524
|
|
|
|
94,255
|
|
Accumulated other comprehensive
income
|
|
|
605
|
|
|
|
569
|
|
Retained earnings
|
|
|
78,829
|
|
|
|
117,524
|
|
|
|
|
|
|
|
|
|
|
Total shareholders equity
|
|
|
168,888
|
|
|
|
212,278
|
|
|
|
|
|
|
|
|
|
|
TOTAL
|
|
$
|
837,801
|
|
|
$
|
878,166
|
|
|
|
|
|
|
|
|
|
|
See the accompanying notes to consolidated financial statements
3
HERBALIFE
LTD.
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
|
March 31,
|
|
|
March 31,
|
|
|
|
2005
|
|
|
2006
|
|
|
|
(Unaudited)
|
|
|
|
(In thousands, except per share
amounts)
|
|
|
Product sales
|
|
$
|
320,224
|
|
|
$
|
393,604
|
|
Handling & freight income
|
|
|
51,836
|
|
|
|
62,184
|
|
|
|
|
|
|
|
|
|
|
Net sales
|
|
|
372,060
|
|
|
|
455,788
|
|
Cost of sales
|
|
|
75,737
|
|
|
|
91,366
|
|
|
|
|
|
|
|
|
|
|
Gross profit
|
|
|
296,323
|
|
|
|
364,422
|
|
Royalty overrides
|
|
|
135,168
|
|
|
|
165,298
|
|
Selling, general &
administrative expenses
|
|
|
110,029
|
|
|
|
135,044
|
|
|
|
|
|
|
|
|
|
|
Operating income
|
|
|
51,126
|
|
|
|
64,080
|
|
Interest expense, net
|
|
|
22,202
|
|
|
|
6,015
|
|
|
|
|
|
|
|
|
|
|
Income before income taxes
|
|
|
28,924
|
|
|
|
58,065
|
|
Income taxes
|
|
|
15,648
|
|
|
|
19,369
|
|
|
|
|
|
|
|
|
|
|
NET INCOME
|
|
$
|
13,276
|
|
|
$
|
38,696
|
|
|
|
|
|
|
|
|
|
|
Earnings per share:
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
0.19
|
|
|
$
|
0.55
|
|
Diluted
|
|
$
|
0.19
|
|
|
$
|
0.53
|
|
Weighted average shares
outstanding:
|
|
|
|
|
|
|
|
|
Basic
|
|
|
68,643
|
|
|
|
69,947
|
|
Diluted
|
|
|
71,714
|
|
|
|
73,451
|
|
See the accompanying notes to consolidated financial statements
4
HERBALIFE,
LTD.
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
|
March 31,
|
|
|
March 31,
|
|
|
|
2005
|
|
|
2006
|
|
|
|
(Unaudited)
|
|
|
|
(In thousands)
|
|
|
CASH FLOWS FROM OPERATING
ACTIVITIES:
|
|
|
|
|
|
|
|
|
Net income
|
|
|
13,276
|
|
|
|
38,696
|
|
Adjustments to reconcile net income
to net cash provided by operating activities:
|
|
|
|
|
|
|
|
|
Depreciation and amortization
|
|
|
10,077
|
|
|
|
7,064
|
|
Excess tax benefits from
share-based payment arrangements
|
|
|
|
|
|
|
(1,491
|
)
|
Amortization of discount and
deferred financing costs
|
|
|
388
|
|
|
|
286
|
|
Deferred income taxes
|
|
|
6,401
|
|
|
|
4,544
|
|
Unrealized foreign exchange loss
(gain)
|
|
|
2,062
|
|
|
|
(537
|
)
|
Write-off of deferred financing
costs and unamortized discounts
|
|
|
3,779
|
|
|
|
181
|
|
Other
|
|
|
1,982
|
|
|
|
2,385
|
|
Changes in operating assets and
liabilities:
|
|
|
|
|
|
|
|
|
Receivables
|
|
|
(11,400
|
)
|
|
|
(7,637
|
)
|
Inventories
|
|
|
358
|
|
|
|
4,886
|
|
Prepaid expenses and other current
assets
|
|
|
(9,265
|
)
|
|
|
(11,156
|
)
|
Accounts payable
|
|
|
5,165
|
|
|
|
(7,492
|
)
|
Royalty overrides
|
|
|
822
|
|
|
|
2,389
|
|
Accrued expenses and accrued
compensation
|
|
|
(7,303
|
)
|
|
|
4,349
|
|
Advance sales deposits
|
|
|
5,675
|
|
|
|
5,926
|
|
Income taxes payable
|
|
|
3,773
|
|
|
|
3,201
|
|
Deferred compensation liability
|
|
|
(698
|
)
|
|
|
530
|
|
|
|
|
|
|
|
|
|
|
NET CASH PROVIDED BY OPERATING
ACTIVITIES
|
|
|
25,092
|
|
|
|
46,124
|
|
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM INVESTING
ACTIVITIES:
|
|
|
|
|
|
|
|
|
Purchases of property
|
|
|
(4,377
|
)
|
|
|
(12,083
|
)
|
Proceeds from sale of property
|
|
|
57
|
|
|
|
46
|
|
Changes in other assets
|
|
|
(643
|
)
|
|
|
(2,407
|
)
|
Deferred compensation plan assets
|
|
|
(579
|
)
|
|
|
(2,623
|
)
|
|
|
|
|
|
|
|
|
|
NET CASH USED IN INVESTING
ACTIVITIES
|
|
|
(5,542
|
)
|
|
|
(17,067
|
)
|
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM FINANCING
ACTIVITIES:
|
|
|
|
|
|
|
|
|
Borrowings from long-term debt
|
|
|
22
|
|
|
|
|
|
Principal payments on long-term debt
|
|
|
(113,232
|
)
|
|
|
(12,286
|
)
|
Exercise of stock options
|
|
|
131
|
|
|
|
806
|
|
Excess tax benefits from
share-based payment arrangements
|
|
|
|
|
|
|
1,491
|
|
Other
|
|
|
(371
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NET CASH USED IN FINANCING
ACTIVITIES
|
|
|
(113,450
|
)
|
|
|
(9,989
|
)
|
|
|
|
|
|
|
|
|
|
EFFECT OF EXCHANGE RATE CHANGES ON
CASH
|
|
|
(3,933
|
)
|
|
|
1,905
|
|
|
|
|
|
|
|
|
|
|
NET CHANGE IN CASH AND CASH
EQUIVALENTS
|
|
|
(97,833
|
)
|
|
|
20,973
|
|
CASH AND CASH EQUIVALENTS,
BEGINNING OF PERIOD
|
|
|
201,577
|
|
|
|
88,248
|
|
|
|
|
|
|
|
|
|
|
CASH AND CASH EQUIVALENTS, END OF
PERIOD
|
|
$
|
103,744
|
|
|
|
109,221
|
|
|
|
|
|
|
|
|
|
|
CASH PAID FOR:
|
|
|
|
|
|
|
|
|
Interest
|
|
$
|
14,900
|
|
|
|
1,673
|
|
|
|
|
|
|
|
|
|
|
Income taxes
|
|
$
|
5,390
|
|
|
|
13,046
|
|
|
|
|
|
|
|
|
|
|
NON-CASH ACTIVITIES:
|
|
|
|
|
|
|
|
|
Acquisitions of property through
capital leases
|
|
$
|
62
|
|
|
$
|
100
|
|
|
|
|
|
|
|
|
|
|
See the accompanying notes to consolidated financial statements
5
HERBALIFE
LTD.
Herbalife Ltd., a Cayman Islands exempted limited liability
company (Herbalife or the Company),
incorporated on April 4, 2002, and its direct and indirect
wholly-owned subsidiaries, WH Intermediate Holdings Ltd., a
Cayman Islands company (WH Intermediate), WH
Luxembourg Holdings S.à.R.L., a Luxembourg unipersonal
limited liability company (Lux Holdings), WH
Luxembourg CM S.à.R.L., a Luxembourg unipersonal limited
liability company, and WH Acquisition Corp., a Nevada
corporation (WH Acquisition), were formed on behalf
of Whitney & Co., LLC (Whitney) and Golden
Gate Private Equity, Inc. (Golden Gate), in order to
acquire Herbalife International, Inc., a Nevada corporation, and
its subsidiaries (Herbalife International) on
July 31, 2002 (the Acquisition). Herbalife and
its subsidiaries are referred to collectively herein as the
Company.
IPO
Recapitalization
On December 16, 2004, Herbalife completed an initial public
offering of its common shares (the IPO), as part of
a series of recapitalization transactions, including:
|
|
|
|
|
a tender offer for $159.8 million of the outstanding
113/4% senior
subordinated notes due 2010 (the
113/4% Notes),
issued by Herbalife International;
|
|
|
|
the replacement of Herbalife Internationals existing
$205.0 million senior credit facility with a new
$225.0 million senior credit facility;
|
|
|
|
the payment of a $139.8 million special cash dividend to
the pre-IPO shareholders of Herbalife; and
|
|
|
|
the amendment of Herbalifes Memorandum and Articles of
Association to: (1) effect a 1:2 reverse stock split of
Herbalifes common shares; (2) increase
Herbalifes authorized common shares to 500 million
shares; and (3) increase Herbalifes authorized
preference shares to 7.5 million shares, all of which took
effect on December 1, 2004.
|
As a planned continuation of the IPO recapitalization, Herbalife
exercised a contract provision in December 2004 to redeem 40%,
or $110.0 million principal value (excluding a premium of
$10.5 million), of the
91/2% notes
due 2011, (the
91/2% Notes).
After the required notice period, this redemption was completed
on February 4, 2005. The redemption premium of
$10.5 million and the write-off of deferred financing fees
of $3.7 million associated with this redemption are
included in interest expense in the first quarter of 2005.
In connection with the IPO and the recapitalization, the Company
incurred $24.7 million in fees and expenses of which
$19.8 million were associated with the IPO (included in
equity) and $4.9 million were associated with the
establishment of the new credit facility (included in deferred
financing costs).
Secondary
Offering
On December 19, 2005, Herbalife completed a secondary
public offering of 13 million common shares held by certain
existing shareholders. The selling shareholders received all net
proceeds from the sale of common shares sold in this offering.
Accordingly, Herbalife did not receive any proceeds from the
sale of common shares.
The unaudited interim financial information of the Company has
been prepared in accordance with Article 10 of the
Securities and Exchange Commissions
Regulation S-X.
Accordingly, it does not include all of the information required
by generally accepted accounting principles for complete
financial statements. The Companys financial statements as
of and for the three months ended March 31, 2006 include
Herbalife and all of its direct and indirect subsidiaries. In
the opinion of management, the accompanying financial
information contains all adjustments, consisting of normal
recurring adjustments, necessary to present fairly the
Companys financial
6
HERBALIFE
LTD.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
statements as of March 31, 2006 and for the three months
ended March 31, 2005 and March 31, 2006. Operating
results for the three months ended March 31, 2006 are not
necessarily indicative of the results that may be expected for
the year ending December 31, 2006.
New
Accounting Pronouncements
Effective January 1, 2006, the Company adopted the fair
value recognition provisions of Statement of Financial
Accounting Standards (SFAS) No. 123R, Share-Based
Payment (SFAS No. 123R), which generally
requires, among other things, that all employee share-based
compensation be measured using a fair value method and that the
resulting compensation cost be recognized in the financial
statements. The Company selected the modified prospective method
of adoption. Under this method, compensation expense that the
Company recognized for the three months ended March 31,
2006 included: (a) compensation expense for all share-based
payments granted prior to, but not yet vested as of
January 1, 2006, based on the grant date fair value
estimated in accordance with the original provisions of SFAS
No. 123, Accounting for Stock-Based Compensation
(SFAS No. 123), and (b) compensation
expense for all share-based payments granted on or after
January 1, 2006, based on the grant date fair value
estimated in accordance with the provisions of SFAS
No. 123R. Results for prior periods were not restated. See
Note 8 to the consolidated financial statements for more
details on stock based compensation.
Reclassifications
Certain reclassifications were made to the prior period
financial statements to conform to current period presentation.
|
|
3.
|
Transactions
with related parties
|
In 2004, Whitney acquired a 50 percent indirect ownership
interest in Shuster Laboratories, Inc. (Shuster), a
provider of product testing and formula development for
Herbalife. Herbalifes total purchases from Shuster for the
three months ended March 31, 2005 and 2006 were $17,000 and
$0, respectively.
In 2004, Whitney acquired a 50 percent indirect ownership
interest in TBA Entertainment (TBA), a provider of
creative services to Herbalife. For the three months ended
March 31, 2005 a payment of $4,577,000 was made to TBA for
services relating to the 25th Anniversary Extravaganza, of
which the majority were reimbursements of Extravaganza expenses
paid to third parties. For the three months ended March 31,
2006, no payments were made to TBA.
In 2004, Golden Gate acquired a 47 percent ownership
interest in Leiner Health Products Inc. (Leiner), a
nutritional manufacturer and supplier of certain Herbalife
products. Total purchases by Herbalife from Leiner during the
three months ended March 31, 2005 and 2006 were $111,000
and $0, respectively.
In January 2005, Whitney, together with its affiliates, acquired
a 77 percent ownership interest in Stauber Performance
Ingredients (Stauber), a value-added distributor of
bulk specialty nutraceutical ingredients. Total purchases by
Herbalife from Stauber for the three months ended March 31,
2005 and 2006 were $100,000 and $3,000, respectively.
7
HERBALIFE
LTD.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Long-term debt consists of the following:
|
|
|
|
|
|
|
|
|
|
|
As of
|
|
|
|
December 31,
|
|
|
March 31,
|
|
|
|
2005
|
|
|
2006
|
|
|
|
(Dollars in millions)
|
|
|
113/4% Notes
|
|
$
|
0.1
|
|
|
$
|
0.1
|
|
Borrowings under senior credit
facility
|
|
|
89.8
|
|
|
|
79.8
|
|
91/2% Notes,
net of unamortized discounts of $3.5 million
(2006) and $3.7 million (2005)
|
|
|
161.3
|
|
|
|
161.5
|
|
Capital leases
|
|
|
5.4
|
|
|
|
4.7
|
|
Other debt
|
|
|
6.5
|
|
|
|
4.9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
263.1
|
|
|
|
251.0
|
|
Less: current portion
|
|
|
9.8
|
|
|
|
8.5
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
253.3
|
|
|
$
|
242.5
|
|
|
|
|
|
|
|
|
|
|
In March 2006, the Company made a prepayment to the term loan
borrowings under the senior credit facility of
$9.8 million. Consequently, the Company expensed
$0.2 million of related unamortized deferred financing
costs in the first quarter of 2006.
The Company is from time to time engaged in routine litigation.
The Company regularly reviews all pending litigation matters in
which it is involved and establishes reserves deemed appropriate
by management for these litigation matters when a probable loss
estimate can be made.
Herbalife International and certain of its independent
distributors have been named as defendants in a purported class
action lawsuit filed February 17, 2005, in the Superior
Court of California, County of San Francisco, and served on
Herbalife International on March 14, 2005
(Minton v. Herbalife International, et al). The
case has been transferred to the Los Angeles County Superior
Court. The plaintiff is challenging the marketing practices of
certain Herbalife International independent distributors and
Herbalife International under various state laws prohibiting
endless chain schemes, insufficient disclosure in
assisted marketing plans, unfair and deceptive business
practices, and fraud and deceit. The plaintiff alleges that the
Freedom Group system operated by certain independent
distributors of Herbalife International products places too much
emphasis on recruiting and encourages excessively large
purchases of product and promotional materials by distributors.
The plaintiff also alleges that Freedom Group pressured
distributors to disseminate misleading promotional materials.
The plaintiff seeks to hold Herbalife International vicariously
liable for the actions of its independent distributors and is
seeking damages and injunctive relief. The Company believes that
it has meritorious defenses to the suit.
Herbalife International and certain of its distributors have
been named as defendants in a class action lawsuit filed
July 16, 2003, in the Circuit Court of Ohio County in the
State of West Virginia (Mey v. Herbalife International,
Inc., et al). On April 21, 2006, the court
granted plaintiffs motion for class certification in West
Virginia. The complaint alleges that certain telemarketing
practices of certain Herbalife International distributors
violate the Telephone Consumer Protection Act, or TCPA, and
seeks to hold Herbalife International vicariously liable for the
practices of its distributors. More specifically, the
plaintiffs complaint alleges that several of Herbalife
Internationals distributors used pre-recorded telephone
messages and autodialers to contact prospective customers in
violation of the TCPAs prohibition of such practices.
Herbalife Internationals distributors are independent
contractors and if any such distributors in fact violated the
TCPA they also violated Herbalifes policies, which
8
HERBALIFE
LTD.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
require its distributors to comply with all applicable federal,
state and local laws. The Company believes that it has
meritorious defenses to the suit.
As a marketer of dietary and nutritional supplements and other
products that are ingested by consumers or applied to their
bodies, the Company has been and is currently, subjected to
various product liability claims. The effects of these claims to
date have not been material to the Company, and the reasonably
possible range of exposure on currently existing claims is not
material. The Company believes that it has meritorious defenses
to the allegations contained in the lawsuits. The Company
currently maintains product liability insurance with an annual
deductible of $10 million.
Certain of the Companys subsidiaries have been subject to
tax audits by governmental authorities in their respective
countries. In certain of these tax audits, governmental
authorities are proposing that significant amounts of additional
taxes and related interest and penalties are due. The Company
and its tax advisors believe that there are substantial defenses
to their allegations that additional taxes are owed, and the
Company is vigorously contesting the additional proposed taxes
and related charges.
These matters may take several years to resolve, and the Company
cannot be sure of their ultimate resolution. However, it is the
opinion of management that adverse outcomes, if any, will not
likely result in a material adverse effect on our financial
condition and operating results. This opinion is based on the
belief that any losses suffered in excess of amounts reserved
would not be material, and that the Company has meritorious
defenses. Although the Company has reserved an amount that the
Company believes represents the most likely outcome of the
resolution of these disputes, if the Company is incorrect in the
assessment the Company may have to record additional expenses.
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
|
March 31,
|
|
|
March 31,
|
|
|
|
2005
|
|
|
2006
|
|
|
Net income
|
|
$
|
13.3
|
|
|
$
|
38.7
|
|
Unrealized gain on derivative
instruments
|
|
|
0.5
|
|
|
|
0.1
|
|
Foreign currency translation
adjustment
|
|
|
0.1
|
|
|
|
(0.1
|
)
|
|
|
|
|
|
|
|
|
|
Comprehensive income
|
|
$
|
13.9
|
|
|
$
|
38.7
|
|
|
|
|
|
|
|
|
|
|
The Company is a network marketing company that sells a wide
range of weight management products, nutritional supplements and
personal care products within one industry segment as defined
under SFAS 131, Disclosures about Segments of an
Enterprise and Related Information. The Companys
products are manufactured by third party providers and then sold
to independent distributors who sell Herbalife products to
retail consumers or other distributors.
The Company sells products in 62 countries throughout the world
and is organized and managed by geographic region. The Company
elected to aggregate its operating segments into one reporting
segment, as management believes that the Companys
operating segments have similar operating characteristics and
similar long term operating performance. In making this
determination, management believes that the operating segments
are similar with regard to the nature of the products sold, the
product acquisition process, the types of customers products are
sold to, the methods used to distribute the products, and the
nature of the regulatory environment.
Revenues reflect sales of products to distributors based on the
distributors geographic location. Sales attributed to the
United States is the same as reported in the geographic
operating information.
9
HERBALIFE
LTD.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The Companys geographic operating information and sales by
product line are as follows:
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
|
March 31,
|
|
|
March 31,
|
|
|
|
2005
|
|
|
2006
|
|
|
|
(In millions)
|
|
|
Net sales:
|
|
|
|
|
|
|
|
|
United States
|
|
$
|
67.0
|
|
|
$
|
81.4
|
|
Mexico
|
|
|
37.4
|
|
|
|
83.5
|
|
Others
|
|
|
267.7
|
|
|
|
290.9
|
|
|
|
|
|
|
|
|
|
|
Total Net sales
|
|
$
|
372.1
|
|
|
$
|
455.8
|
|
|
|
|
|
|
|
|
|
|
Operating margin(1):
|
|
|
|
|
|
|
|
|
United States
|
|
$
|
25.1
|
|
|
$
|
27.8
|
|
Mexico
|
|
|
16.1
|
|
|
|
37.3
|
|
Others
|
|
|
119.9
|
|
|
|
134.0
|
|
|
|
|
|
|
|
|
|
|
Total Operating margin
|
|
$
|
161.1
|
|
|
$
|
199.1
|
|
|
|
|
|
|
|
|
|
|
Selling, general and
administrative expense
|
|
|
110.0
|
|
|
|
135.0
|
|
Interest expense, net
|
|
|
22.2
|
|
|
|
6.1
|
|
|
|
|
|
|
|
|
|
|
Income before income taxes
|
|
|
28.9
|
|
|
|
58.0
|
|
Income taxes
|
|
|
15.6
|
|
|
|
19.3
|
|
|
|
|
|
|
|
|
|
|
Net Income
|
|
$
|
13.3
|
|
|
$
|
38.7
|
|
|
|
|
|
|
|
|
|
|
Net sales by product line:
|
|
|
|
|
|
|
|
|
Weight management
|
|
$
|
151.8
|
|
|
$
|
190.2
|
|
Inner nutrition
|
|
|
160.0
|
|
|
|
200.6
|
|
Outer
Nutrition®
|
|
|
42.6
|
|
|
|
40.9
|
|
Literature, promotional and
other(2)
|
|
|
17.7
|
|
|
|
24.1
|
|
|
|
|
|
|
|
|
|
|
Total Net Sales
|
|
$
|
372.1
|
|
|
$
|
455.8
|
|
|
|
|
|
|
|
|
|
|
Net sales by geographic region:
|
|
|
|
|
|
|
|
|
Americas
|
|
$
|
140.6
|
|
|
$
|
224.1
|
|
Europe
|
|
|
144.6
|
|
|
|
141.5
|
|
Asia/Pacific Rim (excluding Japan)
|
|
|
60.0
|
|
|
|
68.0
|
|
Japan
|
|
|
26.9
|
|
|
|
22.2
|
|
|
|
|
|
|
|
|
|
|
Total Net Sales
|
|
$
|
372.1
|
|
|
$
|
455.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Operating margin consists of net sales less cost of sales and
royalty overrides. |
|
(2) |
|
Product buybacks and returns in all product categories are
included in the literature, promotional and other category. |
10
HERBALIFE
LTD.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
|
|
|
|
|
|
|
|
|
As of
|
|
|
|
December 31,
|
|
|
March 31,
|
|
|
|
2005
|
|
|
2006
|
|
|
|
(In millions)
|
|
|
Total Assets:
|
|
|
|
|
|
|
|
|
United States
|
|
$
|
520.1
|
|
|
$
|
562.5
|
|
Mexico
|
|
|
52.5
|
|
|
|
48.0
|
|
Others
|
|
|
265.2
|
|
|
|
267.7
|
|
|
|
|
|
|
|
|
|
|
Total Assets
|
|
$
|
837.8
|
|
|
$
|
878.2
|
|
|
|
|
|
|
|
|
|
|
|
|
8.
|
Stock
Based Compensation
|
The Company has six stock-based compensation plans which are the
WH Holdings (Cayman Islands) Ltd. Stock Incentive Plan
(Management Plan), the WH Holdings (Cayman
Islands) Ltd. Independent Directors Stock Incentive Plan
(Independent Directors Plan), the Herbalife Ltd.
2004 Incentive Plan (2004 Stock Incentive Plan), the
2005 Stock Incentive Plan (2005 Stock Incentive
Plan), the Herbalife Ltd. Executive Incentive Plan
(Executive Incentive Plan) and the Herbalife Ltd.
Independent Directors Deferred Compensation and Stock Unit Plan
(Independent Director Stock Unit Plan). The
Management Plan provides for the grant of options to purchase
common shares of Herbalife to members of the Companys
management. The Independent Directors Plan provides for the
grant of options to purchase common shares of Herbalife to the
Companys independent directors. The 2004 Stock Incentive
Plan is intended to replace the Management Plan and the
Independent Directors Plan. No additional awards will be made
under either the Management Plan or the Independent Directors
Plan. However, the shares remaining available for issuance under
these plans were absorbed by and became available for issuance
under the 2004 Stock Incentive Plan. The 2005 Stock Incentive
Plan authorizes the issuance of 4,000,000 common shares pursuant
to awards, plus any shares that remain available for issuance
under the 2004 Stock Incentive Plan. The terms of the 2005 Stock
Incentive Plan are substantially similar to the terms of the
2004 Stock Incentive Plan. The purpose of the Executive
Incentive Plan is to govern the award and payment of annual
bonuses to certain company executives. The purpose of the
Independent Directors Stock Unit Plan is to facilitate equity
ownership in the Company by its independent directors through
the award of stock units and to allow for deferral by the
independent directors of compensation realized in connection
with such stock units. The Companys stock compensation
awards outstanding as of March 31, 2006 include stock
options, stock appreciation rights (SARS) and stock
units.
Prior to January 1, 2006, the Company applied the intrinsic
value method as outlined in Accounting Principles Board
(APB) Opinion No. 25, Accounting for
Stock Issued to Employees (APB 25),
and related interpretations, in accounting for share-based
awards made under these plans. Under the intrinsic value method,
compensation expense is recorded on the date of grant to the
extent the then current market price of the underlying stock
exceeds the exercise price. On January 1, 2006, the Company
adopted SFAS No. 123R. This statement replaces
SFAS No. 123 and supersedes APB 25. SFAS
No. 123R requires that all share-based compensation be
recognized as an expense in the financial statements and that
such cost be measured based on the fair value of the awards
granted. The Company adopted SFAS No. 123R using the modified
prospective transition method which requires the recognition of
compensation expense on a prospective basis only. Accordingly,
prior period financial statements have not been restated. Under
this transition method, stock-based compensation cost for the
first quarter of 2006 includes (a) compensation cost for
all share-based awards granted prior to, but not yet vested as
of, January 1, 2006, based on the grant date fair value
estimated in accordance with the original provisions of
SFAS No. 123; and (b) compensation cost for all
share-based awards granted subsequent to January 1, 2006
based on the grant-date fair value estimated in accordance with
the provisions of SFAS No. 123R.
SFAS No. 123R also requires the Company to estimate
forfeitures in calculating the expense relating to share-based
compensation as opposed to recognizing forfeitures as an expense
reduction as they occur. The adjustment to
11
HERBALIFE
LTD.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
apply estimated forfeitures to previously recognized share-based
compensation was considered immaterial and as such was not
classified as a cumulative effect of a change of in accounting
principle.
The Company records compensation expense over the requisite
service period which is equal to the vesting period. For awards
granted prior to January 1, 2006, compensation expense is
recognized on a graded-vesting basis over the vesting term. For
awards granted on or after January 1, 2006, compensation
expense is recognized on a straight-line basis over the vesting
term. For the three months ended March 31, 2005 and 2006,
stock-based compensation expense was included in selling,
general and administrative expenses in the amount of
$1.8 million and $2.4 million, respectively, as well
as related income tax benefits recognized in earnings in the
amount of $0.7 million and $1.0 million, respectively.
As of March 31, 2006, the total unrecognized compensation
cost related to nonvested stock awards was $28.2 million
and the related weighted-average period over which it is
expected to be recognized is approximately 2.3 years.
As a result of the adoption of SFAS No. 123R, the
Companys net income for the three months ended
March 31, 2006 was $1.3 million lower than it would
have been under the Companys previous accounting method
for share-based compensation. Basic and diluted net earnings per
common share for the three months ended March 31, 2006 were
negatively impacted by the change in accounting method by $0.02
and $0.01 per share, respectively. Prior to the
Companys adoption of SFAS No. 123R, benefits of tax
deductions in excess of recognized compensation costs were
reported as operating cash inflows. SFAS No. 123R requires
that these excess tax benefits be recorded as a financing cash
inflow rather than as a reduction of taxes paid. For the three
months ended March 31, 2006, tax benefits of
$1.7 million were generated from option exercises.
The following table illustrates the effect on net income and
earnings per share if the Company had applied the fair value
recognition provision of SFAS No. 123 to options granted
under the Companys stock-based compensation plans for the
three months ended March 31, 2005. For purposes of this pro
forma disclosure, the value of the options is estimated using
the Black-Scholes-Merton option-pricing model and amortized to
expense using a graded vesting schedule with forfeitures
recognized as they occur.
|
|
|
|
|
|
|
Three Months Ended
|
|
|
|
March 31, 2005
|
|
|
|
(In millions)
|
|
|
Net income as reported
|
|
$
|
13.3
|
|
Add: Stock-based employee
compensation expense included in reported net income, net of tax
|
|
|
1.1
|
|
Less: Stock-based employee
compensation expense determined under fair value based methods
for all awards, net of tax
|
|
|
(2.4
|
)
|
|
|
|
|
|
Pro forma net income
|
|
$
|
12.0
|
|
|
|
|
|
|
Basic earnings per share
|
|
|
|
|
As reported
|
|
$
|
0.19
|
|
Pro forma
|
|
$
|
0.17
|
|
Diluted earnings per share
|
|
|
|
|
As reported
|
|
$
|
0.19
|
|
Pro forma
|
|
$
|
0.17
|
|
The Companys stock-based compensation plans provide for
grants of stock options, stock appreciation rights, restricted
stock and stock units (collectively called the
awards). Stock options typically vest quarterly over
a five-year period beginning on the grant date, and certain
stock option grants vest over a period of less than five years.
SARS vest quarterly over a five-year period beginning on the
grant date. The contractual term of stock options and SARS is
ten years. Stock unit awards under the 2005 Incentive Plan
(Incentive Plan Stock Units) vest annually over a
three year period which is equal to the contractual term. Stock
unit awards under the Independent Directors
12
HERBALIFE
LTD.
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Stock Unit Plan (Independent Director Stock Units)
vest at a 25% rate on each of April 15, July 15 and October
15 of the calendar year in which the award is granted and
January 15 of the calendar year following the year in which the
award is granted. Unless otherwise determined at the time of
grant, the value of each stock unit shall be equal to one common
share of Herbalife.
The fair value of each award is estimated on the date of grant
using the Black-Scholes-Merton option-pricing model based on the
assumptions in the following tables. The expected term of the
award is based on observed historical exercise patterns. Because
of the very limited historical data all groups of employees have
been determined to have similar historical exercise patterns for
valuation purposes. The expected volatility of stock awards is
primarily based upon on the historical volatility of the
Companys common stock and, due to the limited period of
public trading data for its common stock, it is also validated
against the volatility rates of a peer group of companies. The
risk free interest rate is based on the implied yield on a
U.S. Treasury zero-coupon issue with a remaining term equal
to the expected term of the award. The dividend yield reflects
that the Company has not paid any cash dividends since
inception. The following table summarizes the weighted average
assumptions used in the calculation of fair market value for the
three months ended March 31, 2005 and 2006.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Incentive Plan
|
|
|
Independent Directors
|
|
|
|
Stock Options
|
|
|
SARS
|
|
|
Stock Units
|
|
|
Stock Units
|
|
|
|
Three Months
|
|
|
Three Months
|
|
|
Three Months
|
|
|
Three Months
|
|
|
|
Ended March 31,
|
|
|
Ended March 31,
|
|
|
Ended March 31,
|
|
|
Ended March 31,
|
|
|
|
2005
|
|
|
2006
|
|
|
2005
|
|
|
2006
|
|
|
2005
|
|
|
2006
|
|
|
2005
|
|
|
2006
|
|
|
Expected volatility
|
|
|
32.75
|
%
|
|
|
37.03
|
%
|
|
|
|
|
|
|
38.62
|
%
|
|
|
|
|
|
|
38.62
|
%
|
|
|
|
|
|
|
37.20
|
%
|
Dividends yield
|
|
|
zero
|
|
|
|
zero
|
|
|
|
|
|
|
|
zero
|
|
|
|
|
|
|
|
zero
|
|
|
|
|
|
|
|
zero
|
|
Expected term
|
|
|
6.3 years
|
|
|
|
6.3 years
|
|
|
|
|
|
|
|
6.3 years
|
|
|
|
|
|
|
|
2.5 years
|
|
|
|
|
|
|
|
3.0 years
|
|
Risk-free interest rate
|
|
|
3.78
|
%
|
|
|
3.94
|
%
|
|
|
|
|
|
|
4.45
|
%
|
|
|
|
|
|
|
3.84
|
%
|
|
|
|
|
|
|
3.41
|
%
|
The following tables summarize the activity under the
stock-based compensation plans for the three months ended
March 31, 2006:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted
|
|
|
|
|
|
|
|
|
|
|
|
|
Average
|
|
|
Aggregate
|
|
|
|
|
|
|
Weighted Average
|
|
|
Remaining
|
|
|
Intrinsic
|
|
Stock Options &
SARS
|
|
Shares
|
|
|
Exercise Price
|
|
|
Contractual Term
|
|
|
Value
|
|
|
|
(In thousands)
|
|
|
|
|
|
|
|
|
(In millions)
|
|
|
Outstanding at December 31,
2005
|
|
|
10,197
|
|
|
$
|
12.30
|
|
|
|
|
|
|
|
|
|
Granted
|
|
|
811
|
|
|
|
32.81
|
|
|
|
|
|
|
|
|
|
Exercised
|
|
|
(155
|
)
|
|
|
5.19
|
|
|
|
|
|
|
|
|
|
Forfeited
|
|
|
(75
|
)
|
|
|
4.52
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at March 31, 2006
|
|
|
10,778
|
|
|
$
|
14.00
|
|
|
|
8.0 years
|
|
|
$
|
213.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable at March 31, 2006
|
|
|
4,228
|
|
|
$
|
10.69
|
|
|
|
8.0 years
|
|
|
$
|
97.6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted Average
|
|
|
|
|
|
|
|
|
|
Grant Date
|
|
|
Aggregate
|
|
Incentive Plan and Independent
Directors Stock Units
|
|
Shares
|
|
|
Fair Value
|
|
|
Fair Value
|
|
|
|
(In thousands)
|
|
|
|
|
|
(In millions)
|
|
|
Outstanding and nonvested at
December 31, 2005
|
|
|
|
|
|
$
|
|
|
|
$
|
|
|
Granted
|
|
|
102.8
|
|
|
|
32.62
|
|
|
|
3.3
|
|
Vested
|
|
|
(4.4
|
)
|
|
|
31.81
|
|
|
|
(0.1
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding and nonvested at
March 31, 2006
|
|
|
98.4
|
|
|
$
|
32.66
|
|
|
$
|
3.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
13
The weighted-average grant date fair value of stock awards
granted during the three months ended March 31, 2005 and
2006 was $6.41 and $17.06, respectively. The total intrinsic
value of stock awards exercised during the three months ended
March 31, 2005 and 2006 was $0.4 million and
$4.3 million, respectively.
|
|
9.
|
Derivative
Instruments and Hedging Activities
|
The Company designates certain derivatives as cash flow hedges.
The Company engages in a foreign exchange hedging strategy for
which the hedged transactions are forecasted foreign currency
denominated intercompany transactions. The hedged risk is the
variability of the forecasted foreign currency cash flows where
the hedging strategy involves the purchase of average rate
options. The Company also engages in an interest rate hedging
strategy for which the hedged transactions are forecasted
interest payments on the Companys variable rate term loan.
The hedged risk is the variability of forecasted interest rate
cash flows, where the hedging strategy involves the purchase of
interest rate swaps. As of December 31, 2005, and
March 31, 2006, the Company did not have any outstanding
cash flow hedges on foreign exchange exposure. For the
outstanding cash flow hedges on interest rate exposures at
December 31, 2005 and March 31, 2006, the maximum
length of time over which the Company is hedging these exposures
is approximately three years. The interest rate swap outstanding
as of December 31, 2005, and March 31, 2006 was
accounted for under the shortcut method, as defined by
SFAS No. 133, which assumes the hedge to be perfectly
effective. Consequently, all changes in the fair value of the
derivative are deferred and recorded in other comprehensive
income (OCI) until the related forecasted
transaction is recognized in the consolidated statements of
income. The estimated net amount of existing gains expected to
be reclassified into earnings over the next three years, which
related to cash flow hedge, is $0.1 million.
The Company designates certain derivatives as free standing
derivatives for which hedge accounting does not apply. The
changes in the fair market value of the derivatives are recorded
in the Companys statements of income. The Company
purchases average rate put options, which give the Company the
right, but not the obligation, to sell foreign currency at a
specified exchange rate (strike rate). These
contracts provide protection in the event the foreign currency
weakens beyond the strike rate. The Company also uses foreign
currency forward contracts, which give the Company the
obligation to buy or sell foreign currency at a specified time
and rate. The contracts are used to protect against changes in
the functional currency equivalent value of inter-company or
third party nonfunctional currency payables and receivables. In
December of 2005, the Company entered into a short term interest
rate cap agreement, which is not designated under hedge
accounting. The cap provides protection in the event the three
month LIBOR rate were to increase beyond 4.75%, and is in place,
along with the interest rate swap, to fulfill the Companys
obligation to hedge at least 25% of the term debt notional
amount. The fair values of the option, forward contracts and
interest rate cap are based on third-party bank quotes.
|
|
Item 2.
|
Managements
Discussion And Analysis Of Financial Condition And Results Of
Operations
|
Overview
We are a global network marketing company that sells weight
management, nutritional supplement and personal care products.
We pursue our mission of changing peoples
lives by providing a financially rewarding business
opportunity to distributors and quality products to distributors
and customers who seek a healthy lifestyle. We are one of the
largest network marketing companies in the world with net sales
of approximately $1.6 billion for the year ended
December 31, 2005. We sell our products in 62 countries
through a network of over one million independent distributors
except in China, where we currently use a retail business model
with employed sales representatives because of regulatory
restrictions on direct selling. We believe the quality of our
products and the effectiveness of our distribution network,
coupled with geographic expansion, have been the primary reasons
for our success throughout our
26-year
operating history.
We offer products in three principal categories: weight
management products, nutritional supplements which we refer to
as inner nutrition and personal care products which
we refer to as Outer
Nutrition®.
Our products are often sold in programs, which are comprised of
a series of related products designed to simplify weight
management and nutrition for our consumers and maximize our
distributors cross-selling opportunities.
14
Industry-wide factors that affect us and our competitors include
the increasing prevalence of obesity and the aging of the
worldwide population, which are driving demand for nutrition and
wellness-related products and the recruitment and retention of
distributors.
The opportunities and challenges upon which we are most focused
are driving retailing of our product, recruitment and retention
of distributors and improving distributor productivity, entering
new markets, further penetrating existing markets, pursuing
local distributor initiatives, introducing new products,
developing niche market segments and further investing in our
infrastructure.
A key non-financial measure we focus on is Volume Points on a
Royalty Basis (hereafter Volume Points), which is
essentially our weighted unit measure of product sales volume.
It is a useful measure for us, as it excludes the impact of
foreign currency fluctuations and ignores the differences
generated by varying retail pricing across geographic markets.
In general, an increase in Volume Points in a particular region
or country directionally indicates an increase in local currency
net sales.
Volume
Points by Geographic Region
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months
|
|
|
|
Ended March 31,
|
|
|
|
2005
|
|
|
2006
|
|
|
% Change
|
|
|
|
(Volume points in
millions)
|
|
|
The Americas
|
|
|
224.5
|
|
|
|
337.0
|
|
|
|
50.1
|
%
|
Europe
|
|
|
144.9
|
|
|
|
148.9
|
|
|
|
2.8
|
%
|
Asia/Pacific Rim
|
|
|
72.4
|
|
|
|
77.1
|
|
|
|
6.5
|
%
|
Japan
|
|
|
18.8
|
|
|
|
17.0
|
|
|
|
(9.5
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Worldwide
|
|
|
460.6
|
|
|
|
580.0
|
|
|
|
25.9
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Another key non-financial measure on which we focus on is the
number of distributors qualified as supervisors under our
compensation system. Distributors qualify for supervisor status
based on their Volume Points.
The growth in the number of supervisors is a general indicator
of the level of distributor recruitment, which generally drives
net sales in a particular country or region. Our compensation
system requires each supervisor to re-qualify for such status
each year, prior to February. There is significant variation in
the number of supervisors from the fourth quarter to the first
quarter of any given year due to the timing of the
re-qualification process. This fluctuation is normal and
consistent, does not reflect a dramatic underlying change in the
business in comparing these two sequential quarters, and will
become more meaningful period to period throughout the year.
The following tables show trends in the number of supervisors
over the reporting period by region, and fluctuations within
each notable country are discussed in the appropriate net sales
section below where pertinent.
Number of
Supervisors by Geographic Region as of Reporting
Period
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of March 31,
|
|
|
|
2005
|
|
|
2006
|
|
|
% Change
|
|
|
The Americas
|
|
|
94,270
|
|
|
|
133,192
|
|
|
|
41.3
|
%
|
Europe
|
|
|
68,810
|
|
|
|
69,537
|
|
|
|
1.1
|
%
|
Asia/Pacific Rim
|
|
|
40,588
|
|
|
|
46,427
|
|
|
|
14.4
|
%
|
Japan
|
|
|
10,165
|
|
|
|
10,080
|
|
|
|
(0.8
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Worldwide
|
|
|
213,833
|
|
|
|
259,236
|
|
|
|
21.2
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15
Number of
Supervisors by Geographic Region as of Requalification
Period
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of February,
|
|
|
|
2005
|
|
|
2006
|
|
|
% Change
|
|
|
The Americas
|
|
|
87,925
|
|
|
|
124,233
|
|
|
|
41.3%
|
|
Europe
|
|
|
65,104
|
|
|
|
66,103
|
|
|
|
1.5%
|
|
Asia/Pacific Rim
|
|
|
38,524
|
|
|
|
43,517
|
|
|
|
13.0%
|
|
Japan
|
|
|
9,547
|
|
|
|
9,719
|
|
|
|
1.8%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Worldwide
|
|
|
201,100
|
|
|
|
243,572
|
|
|
|
21.1%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Supervisors must re-qualify annually. The requalification
period covers the twelve months starting in February and ending
the following January. For the twelve month requalification
period ended January 2006, 41.5% of our supervisors requalified,
up from 39.7% a year ago. The number of supervisors by
geographic region as of the reporting dates will normally be
higher than the number of supervisors by geographic region as of
the requalification period because supervisors who do not
re-qualify during the relevant twelve-month period will be
dropped from the rank of supervisor in February. Since
supervisors purchase most of our products for resale to other
distributors and consumers, comparisons of supervisor totals on
a
year-to-year,
same period basis are good indicators of our recruitment and
retention efforts in different geographic regions.
The value of the average monthly purchase of Herbalife products
by our supervisors has remained relatively constant over time.
Consequently, increases in our sales are driven primarily by our
retention of supervisors and by our recruitment and retention of
distributors, rather than through increases in the productivity
of our overall supervisor base.
We provide distributors with products, support material,
training, special events and a competitive compensation program.
If a distributor wants to pursue the Herbalife business
opportunity, the distributor is responsible for growing his or
her business and personally pays for the sales activities
related to attracting new customers and recruiting distributors
by hosting events such as Herbalife Opportunity Meetings or
Success Training Seminars; by advertising Herbalifes
products, by purchasing and using promotional materials such as
t-shirts, buttons and caps; by utilizing and paying for direct
mail and print material such as brochures, flyers, catalogs,
business cards, posters and banners and telephone book listings;
by purchasing inventory for sale or use as samples; and by
training, mentoring and following up (in person or via the phone
or internet) with customers and recruits on how to use Herbalife
products
and/or
pursue the Herbalife business opportunity.
Presentation
Retail Sales represent the gross sales amounts on
our invoices to distributors before distributor allowances (as
defined below), and net sales, which reflects
distribution allowances and handling and freight income, is what
the Company collects and recognizes as net sales in its
financial statements. We discuss Retail Sales because of its
fundamental role in our compensation systems, internal controls
and operations, including its role as the basis upon which
distributor discounts, royalties and bonuses are awarded. In
addition, information in daily and monthly reports reviewed by
our management relies on Retail Sales data. However, such a
measure is not in accordance with Generally Accepted Accounting
Principles in the U.S. (GAAP). You should not
consider Retail Sales in isolation from, nor is it a substitute
for, net sales and other consolidated income or cash flow
statement data prepared in accordance with GAAP, or as a measure
of profitability or liquidity. A reconciliation of net sales to
Retail Sales is presented below. Product sales
represent the actual product purchase price paid to us by our
distributors, after giving effect to distributor discounts
referred to as distributor allowances, which
approximate 50% of retail sales prices. Distributor allowances
as a percentage of sales may vary by country depending upon
regulatory restrictions that limit or otherwise restrict
distributor allowances.
Our gross profit consists of net sales less
cost of sales, which represents the prices we pay to
our raw material suppliers and manufacturers of our products as
well as costs related to product shipments, duties and tariffs,
freight expenses relating to shipment of products to
distributors and importers and similar expenses.
16
Royalty Overrides are our most significant expense
and consist of:
|
|
|
|
|
royalty overrides, or commissions, and bonuses, which total
approximately 15% and 7%, respectively, of the Retail Sales of
weight management, inner nutrition, Outer
Nutrition®
and promotional products;
|
|
|
|
the Mark Hughes Bonus payable to some of our most senior
distributors in the aggregate amount of up to 1% of Retail Sales
of weight management, inner nutrition, Outer
Nutrition®
and promotional products; and
|
|
|
|
other discretionary incentive cash bonuses to qualifying
distributors.
|
Royalty Overrides are generally earned based on Retail Sales,
and approximate in the aggregate about 22% of Retail Sales or
approximately 35% of our net sales. Royalty Overrides together
with distributor allowances represent the potential earnings to
distributors of up to approximately 73% of Retail Sales. The
compensation to distributors is generally for the development,
retention and improved productivity of their distributor sales
organizations and is paid to several levels of distributors on
each sale. Because of local country regulatory constraints, we
may be required to modify our typical distributor incentive
plans as described above. Because of restrictions on direct
selling in China, our full-time employed sales representatives
in China are compensated with wages, bonuses and benefits
instead of the distributors
earnings distributor allowances and royalty
overrides. Consequently, the total distributor discount
percentage may vary over time. We also offer reduced distributor
allowances and pay reduced royalty overrides with respect to
certain products worldwide.
Our operating margins consist of net sales less cost
of sales and royalty overrides.
Selling, General and Administrative Expenses
represent our operating expenses, components of which include
labor and benefits, sales events, professional fees, travel and
entertainment, distributor marketing, occupancy costs,
communication costs, bank fees, depreciation and amortization,
foreign exchange gains and losses and other miscellaneous
operating expenses.
113/4% Notes
refers to Herbalife Internationals
113/4% senior
subordinated notes due 2010.
91/2% Notes
refers to our
91/2% notes
due 2011.
Most of our sales to distributors outside the United States are
made in the respective local currencies. In preparing our
financial statements, we translate revenues into
U.S. dollars using average exchange rates. Additionally,
the majority of our purchases from our suppliers generally are
made in U.S. dollars. Consequently, a strengthening of the
U.S. dollar versus a foreign currency can have a negative
impact on our reported sales and operating margins and can
generate transaction losses on intercompany transactions.
Throughout the last five years, foreign currency exchange rates
have fluctuated significantly. From time to time, we enter into
foreign exchange forward contracts and option contracts to
mitigate our foreign currency exchange risk.
Summary
Financial Results
For the three months ended March 31, 2006, net sales
increased by 22.5% as compared to the same period in 2005,
primarily driven by increases in the Americas and Asia/Pacific
Rim, partially offset by decreases in Japan and Europe. The
increased sales in the first quarter of 2006 reflected the
continued sales momentum generated from the successful
promotions in 2005 and the enthusiasm and unity within our
distributor organization.
Net income increased for the three months ended March 31,
2006 to $38.7 million, or $0.53 per diluted share,
from $13.3 million, or $0.19 per diluted share for the
same period in 2005. Excluding the impact of a $3.7 million
tax benefit resulting from an international income tax
settlement in the first quarter of 2006 and $14.2 million
of recapitalization expenses incurred in the first quarter of
2005 associated with the $110.0 million clawback of our
91/2%
Notes, net income increased 27.3%. The net income increase was
due to net sales growth, lower interest and income tax expense,
partially offset by higher labor, promotional and professional
fee expenses. Overall, the appreciation of foreign currencies
had a $2.2 million favorable impact on net results for the
three months ended March 31, 2006.
17
Results
of Operations
Our results of operations for the periods described below are
not necessarily indicative of results of operations for future
periods, which depend upon numerous factors, including our
ability to recruit and retain new distributors, open new markets
and further penetrate existing markets and introduce new
products and develop niche market segments.
The following table sets forth selected results of our
operations expressed as a percentage of net sales for the
periods indicated.
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
|
March 31,
|
|
|
March 31,
|
|
|
|
2005
|
|
|
2006
|
|
|
Operations:
|
|
|
|
|
|
|
|
|
Net sales
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
Cost of sales
|
|
|
20.4
|
|
|
|
20.1
|
|
|
|
|
|
|
|
|
|
|
Gross profit
|
|
|
79.6
|
|
|
|
79.9
|
|
Royalty overrides
|
|
|
36.3
|
|
|
|
36.3
|
|
Selling, general & admin
expenses
|
|
|
29.6
|
|
|
|
29.6
|
|
|
|
|
|
|
|
|
|
|
Operating income
|
|
|
13.7
|
|
|
|
14.0
|
|
Interest expense
|
|
|
6.0
|
|
|
|
1.3
|
|
|
|
|
|
|
|
|
|
|
Income before income taxes
|
|
|
7.8
|
|
|
|
12.7
|
|
Income taxes
|
|
|
4.2
|
|
|
|
4.2
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
3.6
|
|
|
|
8.5
|
|
|
|
|
|
|
|
|
|
|
Three
months ended March 31, 2006 compared to three months ended
March 31, 2005
Net
Sales
The following chart reconciles Retail Sales to net sales:
Sales by
Geographic Region
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
March 31,
|
|
|
|
2005
|
|
|
2006
|
|
|
|
|
|
|
|
|
|
|
|
|
Handling
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Handling
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
&
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
&
|
|
|
|
|
|
Change
|
|
|
|
Retail
|
|
|
Distributor
|
|
|
Product
|
|
|
Freight
|
|
|
Net
|
|
|
Retail
|
|
|
Distributor
|
|
|
Product
|
|
|
Freight
|
|
|
Net
|
|
|
in Net
|
|
|
|
Sales
|
|
|
Allowance
|
|
|
Sales
|
|
|
Income
|
|
|
Sales
|
|
|
Sales
|
|
|
Allowance
|
|
|
Sales
|
|
|
Income
|
|
|
Sales
|
|
|
Sales
|
|
|
|
(Dollars in millions)
|
|
|
The Americas
|
|
$
|
231.2
|
|
|
$
|
(111.3
|
)
|
|
$
|
119.9
|
|
|
$
|
20.7
|
|
|
$
|
140.6
|
|
|
$
|
372.6
|
|
|
$
|
(180.1
|
)
|
|
$
|
192.5
|
|
|
$
|
31.6
|
|
|
$
|
224.1
|
|
|
|
59.4
|
%
|
Europe
|
|
|
236.5
|
|
|
|
(112.8
|
)
|
|
|
123.7
|
|
|
|
20.9
|
|
|
|
144.6
|
|
|
|
232.3
|
|
|
|
(111.3
|
)
|
|
|
121.0
|
|
|
|
20.5
|
|
|
|
141.5
|
|
|
|
(2.1
|
)%
|
Asia/Pacific Rim
|
|
|
99.0
|
|
|
|
(46.1
|
)
|
|
|
52.9
|
|
|
|
7.1
|
|
|
|
60.0
|
|
|
|
107.9
|
|
|
|
(47.3
|
)
|
|
|
60.6
|
|
|
|
7.4
|
|
|
|
68.0
|
|
|
|
13.4
|
%
|
Japan
|
|
|
46.3
|
|
|
|
(22.6
|
)
|
|
|
23.7
|
|
|
|
3.2
|
|
|
|
26.9
|
|
|
|
38.3
|
|
|
|
(18.8
|
)
|
|
|
19.5
|
|
|
|
2.7
|
|
|
|
22.2
|
|
|
|
(17.5
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
613.0
|
|
|
$
|
(292.8
|
)
|
|
$
|
320.2
|
|
|
$
|
51.9
|
|
|
$
|
372.1
|
|
|
$
|
751.1
|
|
|
$
|
(357.5
|
)
|
|
$
|
393.6
|
|
|
$
|
62.2
|
|
|
$
|
455.8
|
|
|
|
22.5
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Changes in net sales are directly associated with the
recruiting, retention and retailing of our distributor force,
the quality and completeness of the product offerings that the
distributor force has to sell and the number of countries in
which we operate. Managements role, both in-country and at
the corporate level is to provide distributors with a
competitive and broad product line, encourage strong teamwork
and leadership among the Chairmans Club and
Presidents Team distributors and offer leading edge
business tools to make doing business with Herbalife simple.
Management uses the marketing program coupled with educational
and motivational tools to incentivize distributors to drive
recruiting, retention and retailing which in turn affect net
sales. Such tools include corporate sales
events Extravaganzas and World Team
Schools where large groups of distributors
gather, thus
18
allowing them to network with other distributors, learn
recruiting, retention and retailing techniques from our leading
distributors, and become more familiar with how to market and
sell our products and business opportunities. Accordingly,
management believes that these development and motivation
programs can increase the productivity of the supervisor
network. The expenses for such programs are included in selling,
general & administrative expenses. Sales are driven by
several factors including the number and productivity of
distributor leaders who continually build, educate and motivate
their respective distribution and sales organizations. We also
use product event and non-event promotions to motivate
distributors to increase recruiting, retention and retailing
activities. These promotions have ranged from our 2003 laptop
computer promotion to vacations or other qualifying events for
distributors that meet certain selling and recruiting goals. The
costs of these promotions are included in selling,
general, & administrative expenses.
The factors described above have driven growth in our business.
The following net sales by geographic region discussion further
details some of the above factors and describes unique growth
factors specific to certain major countries. The Company
believes that the correct foundation, coupled with ongoing
training and promotional initiatives is required to increase
recruiting and retention of distributors and retailing of the
product. The correct foundation includes strong country
management that works closely with the distributor leadership, a
broad product line that appeals to local consumer needs, a
favorable regulatory environment, a scalable and stable
technology platform and an attractive marketing plan.
Initiatives such as Success Training Seminars, World Team
Schools, Promotional Events and regional Extravaganzas are
integral components of developing a highly motivated and
educated distributor sales organization that will work toward
increasing the recruitment and retention of distributors.
The Companys strategy will continue to include generating
and maintaining growth within existing markets. We expect to
increase spending in selling, general & administrative
expenses to maintain or stimulate sales growth, while making
strategic investments in new initiatives. In addition, new ideas
are being generated in our regional markets, either by
distributors, country management or corporate management.
Examples are the Nutrition Clubs in Mexico and the Total Plan in
Brazil and GenerationH (GenH) in the U.S., as
described in the net sales discussion below. Managements
strategy is to review the applicability of expanding successful
country initiatives throughout a region
and/or
globally where appropriate and financially support the
globalization of these initiatives.
The
Americas
Net sales in The Americas increased $83.5 million, or
59.4%, for the three months ended March 31, 2006, as
compared to 2005. In local currency, net sales increased by
51.6% for the three months ended March 31, 2006, as
compared to 2005. The fluctuation of foreign currency rates had
a favorable impact of $11.0 million on net sales for three
months ended March 31, 2006. The overall increase was a
result of net sales growth in Mexico, Brazil and U.S. of
$46.1 million, $12.1 million and $14.4 million,
respectively, or 123.2%, 51.8%, and 21.5%, respectively, for the
three months ended March 31, 2006.
The net sales growth trend in Mexico reflects the continued
emphasis on distributor and customer retention programs such as
the Nutrition Clubs, which are an innovative way by which
distributors are retailing our products to new customers, some
of whom may eventually become distributors of our products. The
costs to set up a Nutrition Club are generally nominal, and are
borne solely by the distributor. Our distributors are operating
over 25,000 Nutrition Clubs in Mexico. During the first quarter
we opened an additional sales center in Mexico City and held a
Presidents Team Tour attended by approximately 9,000
distributors. In the second quarter of 2006 we plan to move our
local headquarter and main warehouse to a new location to better
support the increased sales. In connection with the relocation
we expect to invest approximately $2.4 million in leasehold
improvements, equipment and technology hardware.
The net sales growth trend in Brazil is a result of the
expansion of the Total Plan, strong distributor leadership, a
highly effective country management team and a good product
portfolio. The Total Plan is a low cost lead generating method
where distributors use our personal care line of products and
offer consultations to obtain referrals. This concept
specifically supports our retailing and recruiting initiatives
and has been a catalyst for growth in Brazil. In December 2005,
Brazil held its
10th Anniversary
Event, with over 10,000 distributors in attendance. At this
event, new products (Firm Cell, Radiant C Scrub, Cleanser and
Body Lotion) were launched that further support
19
the Total Plan, reinforcing our objective to increase the
recruitment, retailing and retention by distributors. A
demonstration of our online distributor tool, BizWorks, was also
provided to highlight the benefits of real time organizational
volume reports as a means to improve efficiency for
distributors. The positive momentum from this event has
continued into the first quarter of 2006.
Net sales growth in the U.S. is a result of the numerous
steps taken in 2004, 2005 and the first quarter of 2006 to
improve the business in the U.S., including the establishment of
a dedicated U.S. country management team; branding efforts
such as sponsorship of the JP Morgan Chase tennis tournament,
the AVP Volleyball Tour, the Nautica Malibu Triathlon and the
2006 Amgen Tour of California bicycle race; various new
promotions including the 2006 Active World Team promotion and
the 2006 President Team Challenge; and various new product
introductions in late 2005. These steps have helped maintain the
positive net sales growth during the first quarter of 2006. It
is our plan to open two new sales centers in the
U.S. during the second half of 2006 to further support the
overall sales growth and in particular to stimulate sales within
the vicinity of the new sales centers.
We believe that 2006 sales in the Americas region should
continue its positive year over year growth primarily as a
result of the expected continuation of the strong momentum in
Mexico, Brazil, and the U.S.
Europe
Net sales in Europe decreased $3.1 million, or 2.2%, for
the three months ended March 31, 2006, as compared to 2005.
In local currency, net sales increased 5.5% for the three months
ended March 31, 2006, as compared to 2005. The fluctuation
of foreign currency rates had an unfavorable impact on net sales
of $11.1 million for the three months ended March 31,
2006. Germany, Netherlands and Switzerland continue to
experience sales declines of 20.8%, 23.8% and 25.0%,
respectively, while France and Italy increased net sales by
29.6% and 8.0%, respectively, for the three months ended
March 31, 2006, as compared to 2005. During the quarter we
re-located our call centers to Italy, France and the Netherlands
in an effort to improve service and support to distributors, who
previously were serviced out of the United Kingdom. During this
process we also opened our first sales center in the Netherlands.
The decline in the Netherlands has been primarily driven by
lower recruiting of new distributors. A reconstituted
distributor strategy group, working closely with regional
management is focused on initiatives to reverse that trend. New
distributor business tools and the sponsorship of the Rotterdam
Marathon are direct results of these efforts.
In Germany and Switzerland, a newly constituted strategy group
is focusing on turnaround initiatives, both on business activity
as well as brand building. Recent in-country trainings by top
distributors on key initiatives such as the Total Plan have
evolved from this group.
While progress is being made, the turnaround is expected to be
slow in all three of the above markets, and net sales for 2006
are expected to be slightly below the level of 2005 for these
countries.
The net sales increases in Italy and France are primarily due to
a well balanced performance across distributor retailing,
recruiting and retention efforts, a united distributor
leadership working closely with the local management, and a
program focus on the Total Plan as referred to above. In
addition, in France there is an increasing emphasis on good
health and nutrition, which is supported and promoted by local
nutritionists.
We believe that 2006 sales in Europe should continue the
positive year over year growth as measured in local currencies,
partly due to our global and local branding initiatives, such as
sponsoring the London Triathlon, the Belgium Gezond Wandeldag
Fun Run and the Madrid Triathlon, which are intended to
continually improve our corporate and brand reputation in the
market and our introduction of new products into the region,
such as
Liftofftm,
scheduled for launch during the second and third quarters of
2006. In addition, with the recent changes to our management
teams, both regionally and locally, we expect to formulate and
implement a new strategy to improve the declining markets in
Europe and continue positive growth trends in others.
Asia/Pacific
Rim
Net sales in Asia/Pacific Rim increased $8.0 million, or
13.3%, for the three months ended March 31, 2006, as
compared to 2005. In local currency, net sales increased 13.6%
for the three months ended March 31, 2006, as
20
compared to 2005. The fluctuation of foreign currency rates had
a $0.2 million unfavorable impact on net sales for the
three months ended March 31, 2006. The overall increase was
attributable mainly to increases in South Korea, China and the
opening of Malaysia in February 2006.
Net sales in South Korea increased $3.5 million, or 35.4%,
for the three months ended March 31, 2006, as compared to
2005. This continued improvement in 2006 was a result of
positive momentum from the local events including leadership
weekends and a unified focus by Koreas country and
distributor leadership. Also, during the first quarter of 2006
we made some modifications to the local distributor compensation
plan, which we expect to have a positive impact on recruiting in
2006.
Net sales in China increased $4.0 million to
$4.3 million for the three months ended March 31,
2006, as compared to 2005. Since March of 2005 we have opened 19
retail stores in 9 provinces throughout China. We expect to
increase the number of stores to cover approximately 20
provinces before the end of 2006.
Malaysia opened in February 2006 with over 10,000 attendees at
various opening events. Net sales for the three months ended
March 31, 2006 was $3.9 million.
Net sales in Taiwan decreased $3.5 million, or 14.7%, for
the three months ended March 31, 2006, as compared to 2005.
The decrease was primarily attributed to the local distributor
leadership and some of their key members directed their focus on
the opening of Malaysia and the emerging business opportunity in
China.
Overall, we believe that additional promotions, various branding
initiatives including the sponsorship of several healthy
lifestyle events in the region, the opening of Malaysia, the
further expansion into the Chinese market, the expansion of
Nutrition Clubs within the region and new product introduction,
should continue the regions positive year over year growth.
Japan
Net sales in Japan decreased $4.7 million, or 17.5%, for
the three months ended March 31, 2006, as compared to 2005.
In local currency, net sales in Japan decreased 7.4% for the
three months ended March 31, 2006, as compared to 2005. The
fluctuation of foreign currency rates had an unfavorable
$2.7 million impact on net sales for the three months ended
March 31, 2006. After two consecutive quarters of year over
year sales growth as measured in local currencies, the current
quarter decline was primarily due to the introduction of
Shapeworkstm
in the first quarter of 2005 and the timing of certain
promotions. Such promotions and significant product
introductions were not repeated in 2006. The number of new
distributors and the supervisor retention rate are improving
when compared to the same period last year. The improved
retention rate was caused by a shift in distributors taking
advantage of the modified re-qualification criteria, a criteria
we believe will lead to increased future sales and exceed the
immediate negative impact on sales.
Sales by
Product Category
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
March 31,
|
|
|
|
2005
|
|
|
2006
|
|
|
|
|
|
|
|
|
|
|
|
|
Handling
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Handling &
|
|
|
|
|
|
|
|
|
|
Retail
|
|
|
Distributor
|
|
|
Product
|
|
|
& Freight
|
|
|
Net
|
|
|
Retail
|
|
|
Distributor
|
|
|
Product
|
|
|
Freight
|
|
|
Net
|
|
|
% Change in
|
|
|
|
Sales
|
|
|
Allowance
|
|
|
Sales
|
|
|
Income
|
|
|
Sales
|
|
|
Sales
|
|
|
Allowance
|
|
|
Sales
|
|
|
Income
|
|
|
Sales
|
|
|
Net Sales
|
|
|
|
(Dollars in millions)
|
|
|
Weight Management
|
|
$
|
256.7
|
|
|
$
|
(126.6
|
)
|
|
$
|
130.1
|
|
|
$
|
21.7
|
|
|
$
|
151.8
|
|
|
$
|
322.5
|
|
|
$
|
(159.0
|
)
|
|
$
|
163.5
|
|
|
$
|
26.7
|
|
|
$
|
190.2
|
|
|
|
25.3
|
%
|
Inner Nutrition
|
|
|
270.6
|
|
|
|
(133.5
|
)
|
|
|
137.1
|
|
|
|
22.9
|
|
|
|
160.0
|
|
|
|
340.2
|
|
|
|
(167.8
|
)
|
|
|
172.4
|
|
|
|
28.2
|
|
|
|
200.6
|
|
|
|
25.4
|
%
|
Outer
Nutrition®
|
|
|
72.0
|
|
|
|
(35.5
|
)
|
|
|
36.5
|
|
|
|
6.1
|
|
|
|
42.6
|
|
|
|
69.4
|
|
|
|
(34.2
|
)
|
|
|
35.2
|
|
|
|
5.7
|
|
|
|
40.9
|
|
|
|
(4.0
|
)%
|
Literature, Promotional and Other
|
|
|
13.7
|
|
|
|
2.8
|
|
|
|
16.5
|
|
|
|
1.2
|
|
|
|
17.7
|
|
|
|
19.0
|
|
|
|
3.5
|
|
|
|
22.5
|
|
|
|
1.6
|
|
|
|
24.1
|
|
|
|
36.2
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
613.0
|
|
|
$
|
(292.8
|
)
|
|
$
|
320.2
|
|
|
$
|
51.9
|
|
|
$
|
372.1
|
|
|
$
|
751.1
|
|
|
$
|
(357.5
|
)
|
|
$
|
393.6
|
|
|
$
|
62.2
|
|
|
$
|
455.8
|
|
|
|
22.5
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Our increased emphasis on the science of weight management and
nutrition during the past two years, illustrated by our assembly
of the Scientific Advisory Board and the Medical Advisory Board,
has resulted in product introductions such as
Niteworkstm
and Garden
7tm
and the introduction of
ShapeWorkstm,
a personalized meal replacement program. Due to the launch these
new products together with the continued positive sales
21
momentum discussed above, net sales of weight management
products and Inner
Nutrition®
products increased at a higher rate than net sales of inner
nutrition products. Literature, Promotional and Other, which is
net of product buy-backs and returns in all product categories,
increased due to a decrease in returns and refunds. We expect
shifts within these categories from time to time as we launch
new products.
Gross
Profit
Gross profit was $364.4 million for the three months ended
March 31, 2006, as compared to $296.3 million in the
same period of 2005. As a percentage of net sales, gross profit
for the three months ended March 31, 2006 increased
slightly from 79.6% to 80.0%, as compared to the same period of
2005. Generally, gross profit percentages do not vary
significantly as a percentage of sales other than due to ongoing
cost reduction initiatives and provisions for slow moving and
obsolete inventory. Additionally, we believe that we have the
ability to mitigate price increases by raising the prices of our
products or shifting product sourcing to alternative
manufacturers.
Royalty
Overrides
Royalty Overrides as a percentage of net sales were 36.3% for
the three months ended March 31, 2006 and March 31,
2005. Generally, this ratio varies slightly from period to
period due to changes in the mix of products and countries
because full Royalty Overrides are not paid on certain products
or in certain countries. Due to the structure of our global
compensation plan, we do not expect to see significant
fluctuations in Royalty Overrides as a percent of net sales.
Selling,
General, & Administrative Expenses
Selling, General, & Administrative expenses as a
percentage of net sales were 29.6% for the three months ended
March 31, 2006 and March 31, 2005, respectively.
For the three months ended March 31, 2006, Selling,
General & Administrative expenses increased
$25.0 million to $135.0 million from
$110.0 million in the same period of 2005. The increase
included $11.0 million in higher salaries and benefits, due
primarily to normal merit increases, higher employee bonuses,
higher stock based compensation expenses, increases related to
the strengthening of the management team regionally and in the
U.S.; higher compensation costs associated with employee sales
representatives in China; and $5.6 million in additional
professional fees primarily associated with our technology
infrastructure and legal expenses; and $3.9 million in
additional sales event expenses related primarily to the Chile
Extravaganza and Herbalife Honors, our most prestigious award
ceremony.
We expect 2006 Selling, General & Administrative
expenses to increase over 2005 levels, reflecting general salary
merit increases and the on-going investments in our five key
strategiesdistributor, direct-to-consumer, product
development, China, and infrastructure strategies. Although as a
percentage of net sales, these expenses should be slightly down
from 2005 levels.
Net
Interest Expense
Net interest expense was $6.0 million for the three months
ended March 31, 2006, as compared to $22.2 million in
the same period of 2005 reflecting the lower level of debt, from
the redemption of 40% or $110 million principal amount of
the
91/2% Notes
completed in February 2005.
Income
Taxes
Income taxes were $19.4 million for the three months ended
March 31, 2006, as compared to $15.6 million in the
same period of 2005. As a percentage of pre-tax income, the
effective income tax rate was 33.4% for the three months ended
March 31, 2006, as compared to 54.1% in the same period of
2005. The decrease in the effective tax rate for the three
months ended March 31, 2006 as compared to 2005 was caused
primarily by the higher pre-tax income, the impact of
non-deductible recapitalization charges in the three months
ended March 31, 2005 and the settlement of an international
tax audit in the three months ended March 31, 2006.
Excluding the impact of the
22
recapitalization expenses and the completion of the
international tax audit, the effective tax rate would have been
approximately 39.7% and 37% for the three months ended
March 31, 2006 and March 31, 2005, respectively.
Foreign
Currency Fluctuations
Currency fluctuations had a favorable impact of
$2.2 million on net results for the three months ended
March 31, 2006, when compared to what current year net
results would have been using last years foreign exchange
rates. For the three months ended March 31, 2006, the
regional effects of currency fluctuations were an unfavorable
impact of $1.4 million in Europe, an unfavorable impact of
$0.2 million in Asia/Pacific Rim, a favorable impact of
$3.1 million in The Americas, and a favorable impact of
$0.7 million in Japan.
Net
Results
Net income for the three months ended March 31, 2006 was
$38.7 million, or $0.53 per diluted share, up from
$13.3 million, or $0.19 per diluted share for the same
period of 2005. Excluding the impact of a $3.7 million tax
benefit resulting from an international income tax settlement in
the first quarter of 2006 and $14.2 million of
recapitalization expenses incurred in the first quarter of 2005
associated with the $110.0 million clawback of our
91/2% Notes,
net income increased 27.3%. The increase in net income was due
to the net sales growth, lower interest and income tax expense,
partially offset by higher labor, promotional and professional
fee expenses. Overall, the appreciation of foreign currencies
had a $2.2 million favorable impact on net results for the
three months ended March 31, 2006.
Liquidity
and Capital Resources
We have historically met our working capital and capital
expenditure requirements, including funding for expansion of
operations, through net cash flows provided by operating
activities. Our principal source of liquidity is our operating
cash flows. Variations in sales of our products would directly
affect the availability of funds. There are no material
restrictions on the ability to transfer and remit funds among
our international affiliated companies.
For the three months ended March 31, 2006, we generated
$46.1 million from operating cash flows, as compared to
$25.1 million for the three months ended March 31,
2005. The increase in cash generated from operations reflected
an increase in net income of $25.4 million, which was
primarily driven by a 22.5% growth in net sales and a decrease
in interest paid of $13.2 million, partially offset by an
increase in income taxes paid of $7.7 million and the
timing of the Mark Hughes Bonus payment. In 2006, we made
$24.6 million of Mark Hughes Bonus payments in March 2006.
In 2005, the Mark Hughes Bonus payments were paid in April 2005.
Capital expenditures, including capital leases, for the three
months ended March 31, 2006 were $12.2 million, as
compared to $4.4 million for the same period in 2005. The
majority of these expenditures represented investments in
management information systems, the development of the
Companys
direct-to-consumer
platform, and the expansion of our facilities in China. We
expect to incur capital expenditures of up to $45 million
in 2006.
2005 and 2006 are investment years for us in China as we expand
our business there. The operating loss in China for 2005 was
$2.2 million and we currently anticipate to fund an
operating loss of approximately $10.0 million in 2006, in
addition to total capital expenditures and working capital of up
to $15.0 million for the planned build-out of retail
stores, our offices and the expansion of the capabilities of our
manufacturing facility. In 2005 we invested approximately
$4.5 million in capital expenditures in China.
In December 2004, Herbalife completed an initial public offering
in connection with which several recapitalization transactions
were completed, including the tender for all of the outstanding
113/4% Notes,
of which 99.9% accepted the tender offer, and a replacement of
the existing term loan and revolving credit facility with a new
$225.0 million senior credit facility. In addition, we
redeemed $110 million principal amount excluding discounts
or 40% of our outstanding
91/2% Notes
in February of 2005 for the cash amount of $124.1 million,
including a premium of $10.5 million and accrued interest
of $3.6 million. Interest expense in 2005 includes the
redemption amount of $14.2 million, which represents
$10.5 million of premium and $3.7 million of write off
of deferred financing cost and discount.
23
The $225.0 million senior credit facility consists of a
senior secured revolving credit facility with total availability
of up to $25.0 million and a senior secured term loan
facility in an aggregate principal amount of
$200.0 million. The revolver is available until
December 21, 2009. The revolver bears interest at LIBOR
plus 2%. In April 2005 the senior credit facility was amended
whereby the interest rate was reduced from LIBOR plus
21/4%
to LIBOR plus
13/4%.
In addition, the amount payable in connection with a partial or
full refinancing of the loan within the first year of the
amendment shall equal 101% of the principal amount. In August
2005, the senior credit facility was amended to permit the
purchase, repurchase or redemption of up to $50.0 million
aggregate principal amount of the
91/2% Notes
due 2011. There were no repurchases of the
91/2% Notes
in 2005 and 2006. In March 2006, we prepaid $9.8 million of
our senior credit facility resulting in approximately
$0.2 million additional interest expense from write-off of
deferred financing fees. With regard to the term loan we are
obligated to pay $0.2 million every quarter until
September 30, 2010 and the remaining principal amount on
December 21, 2010.
The senior credit facility and the
91/2% Notes
include customary covenants that restrict, among other things,
the ability to incur additional debt, pay dividends or make
certain other restricted payments, incur liens, merge or sell
all or substantially all of our assets, or enter into various
transactions with affiliates. Additionally, the senior credit
facility includes covenants relating to the maintenance of
certain leverage, fixed charge coverage, and interest coverage
ratios, and requirements to make early payments to the extent of
excess cash flow, as defined therein.
The following summarizes our contractual obligations including
interest at March 31, 2006 and the effect such obligations
are expected to have on our liquidity and cash flows in future
periods:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Payments Due by Period
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2011 &
|
|
|
|
Total
|
|
|
2006
|
|
|
2007
|
|
|
2008
|
|
|
2009
|
|
|
2010
|
|
|
Thereafter
|
|
|
|
(In millions)
|
|
|
Senior Secured Term Loan
|
|
$
|
103.9
|
|
|
$
|
4.5
|
|
|
$
|
6.0
|
|
|
$
|
5.9
|
|
|
$
|
5.9
|
|
|
$
|
81.6
|
|
|
$
|
|
|
113/4% Notes
|
|
|
0.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.2
|
|
|
|
|
|
91/2% Notes
|
|
|
251.2
|
|
|
|
15.7
|
|
|
|
15.7
|
|
|
|
15.7
|
|
|
|
15.7
|
|
|
|
15.7
|
|
|
|
172.7
|
|
Capital Lease
|
|
|
4.8
|
|
|
|
2.7
|
|
|
|
1.9
|
|
|
|
0.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other debt
|
|
|
5.0
|
|
|
|
4.1
|
|
|
|
0.9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating leases
|
|
|
76.6
|
|
|
|
13.3
|
|
|
|
11.4
|
|
|
|
8.0
|
|
|
|
7.1
|
|
|
|
7.0
|
|
|
|
29.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
441.7
|
|
|
$
|
40.3
|
|
|
$
|
35.9
|
|
|
$
|
29.8
|
|
|
$
|
28.7
|
|
|
$
|
104.5
|
|
|
$
|
202.5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of March 31, 2006, we had positive working capital of
$43.2 million. Cash and cash equivalents were
$109.2 million at March 31, 2006, compared to
$88.2 million at December 31, 2005.
We expect that cash and funds provided from operations and
available borrowings under our new revolving credit facility
will provide sufficient working capital to operate our business,
to make expected capital expenditures and to meet foreseeable
liquidity requirements, including debt service on the
91/2% Notes
and the new senior credit facility. There can be no assurance,
however, that our business will service our debt, including our
outstanding notes, or fund our other liquidity needs.
The majority of our purchases from suppliers are generally made
in U.S. dollars, while sales to Herbalife distributors
generally are made in local currencies. Consequently,
strengthening of the U.S. dollar versus a foreign currency
can have a negative impact on operating margins and can generate
transaction losses on intercompany transactions. For discussion
of our foreign exchange contracts and other hedging
arrangements, see the quantitative and qualitative disclosures
about market risks described below.
Contingencies
We are from time to time engaged in routine litigation. We
regularly review all pending litigation matters in which we are
involved and establish reserves deemed appropriate by management
for these litigation matters when a probable loss estimate can
be made.
Herbalife International and certain of its independent
distributors have been named as defendants in a purported class
action lawsuit filed February 17, 2005, in the Superior
Court of California, County of San Francisco,
24
and served on Herbalife International on March 14, 2005
(Minton v. Herbalife International,
et al). The case has been transferred to the Los
Angeles County Superior Court. The plaintiff is challenging the
marketing practices of certain Herbalife International
independent distributors and Herbalife International under
various state laws prohibiting endless chain
schemes, insufficient disclosure in assisted marketing
plans, unfair and deceptive business practices, and fraud and
deceit. The plaintiff alleges that the Freedom Group system
operated by certain independent distributors of Herbalife
International products places too much emphasis on recruiting
and encourages excessively large purchases of product and
promotional materials by distributors. The plaintiff also
alleges that Freedom Group pressured distributors to disseminate
misleading promotional materials. The plaintiff seeks to hold
Herbalife International vicariously liable for the actions of
its independent distributors and is seeking damages and
injunctive relief. The Company believes that it has meritorious
defenses to the suit.
Herbalife International and certain of its distributors have
been named as defendants in a class action lawsuit filed
July 16, 2003, in the Circuit Court of Ohio County in the
State of West Virginia (Mey v. Herbalife International,
Inc., et al). On April 21, 2006, the court
granted plaintiffs motion for class certification in West
Virginia. The complaint alleges that certain telemarketing
practices of certain Herbalife International distributors
violate the Telephone Consumer Protection Act, or TCPA, and
seeks to hold Herbalife International vicariously liable for the
practices of its distributors. More specifically, the
plaintiffs complaint alleges that several of Herbalife
Internationals distributors used pre-recorded telephone
messages and autodialers to contact prospective customers in
violation of the TCPAs prohibition of such practices.
Herbalife Internationals distributors are independent
contractors and if any such distributors in fact violated the
TCPA they also violated Herbalifes policies, which require
its distributors to comply with all applicable federal, state
and local laws. The Company believes that it has meritorious
defenses to the suit.
As a marketer of dietary and nutritional supplements and other
products that are ingested by consumers or applied to their
bodies, we have been and are currently subjected to various
product liability claims. The effects of these claims to date
have not been material to us, and the reasonably possible range
of exposure on currently existing claims is not material to us.
We believe that we have meritorious defenses to the allegations
contained in the lawsuits. We currently maintain product
liability insurance with an annual deductible of
$10 million.
Certain of our subsidiaries have been subject to tax audits by
governmental authorities in their respective countries. In
certain of these tax audits, governmental authorities are
proposing that significant amounts of additional taxes and
related interest and penalties are due. We and our tax advisors
believe that there are substantial defenses to their allegations
that additional taxes are owed, and we are vigorously contesting
the additional proposed taxes and related charges.
These matters may take several years to resolve, and we cannot
be sure of their ultimate resolution. However, it is the opinion
of management that adverse outcomes, if any, will not likely
result in a material effect on our financial condition and
operating results. This opinion is based on our belief that any
losses we suffer would not be material and that we have
meritorious defenses. Although we have reserved an amount that
we believe represents the likely outcome of the resolution of
these disputes, if we are incorrect in our assessment we may
have to record additional expenses.
Critical
Accounting Policies
Our Consolidated Financial Statements are prepared in conformity
with accounting principles generally accepted in the United
States, which require us to make estimates and assumptions that
affect the reported amounts of assets and liabilities and
disclosures of contingent assets and liabilities at the date of
the financial statements and the reported amounts of revenue and
expenses during the year. Actual results could differ from those
estimates. We consider the following policies to be most
critical in understanding the judgments that are involved in
preparing the financial statements and the uncertainties that
could impact our results of operations, financial condition and
cash flows.
We are a network marketing company that sells a wide range of
weight management products, nutritional supplements and personal
care products within one industry segment as defined under
SFAS 131, Disclosures about Segments of an Enterprise
and Related Information. Our products are manufactured by
third party providers and then sold to independent distributors
who sell Herbalife products to retail consumers or other
distributors.
25
We sell products in 62 countries throughout the world and is
organized and managed by geographic region. In the first quarter
of 2003, we elected to aggregate our operating segments into one
reporting segment, as management believes that our operating
segments have similar operating characteristics and similar long
term operating performance. In making this determination,
management believes that the operating segments are similar in
the nature of the products sold, the product acquisition
process, the types of customers products are sold to, the
methods used to distribute the products, and the nature of the
regulatory environment.
Revenue is recognized when products are shipped and title passes
to the independent distributor or importer. Amounts billed for
freight and handling costs are included in net sales. We
generally receive the net sales price in cash or through credit
card payments at the point of sale. Related royalty overrides
and allowances for product returns are recorded when the
merchandise is shipped.
Allowances for product returns primarily in connection with our
buyback program are provided at the time the product is shipped.
This accrual is based upon historic return rates for each
country, which vary from zero to approximately 5.0% of retail
sales, and the relevant return pattern, which reflects
anticipated returns to be received over a period of up to
12 months following the original sale. Historically,
product returns and buybacks have not been significant. Product
returns and buybacks were approximately 0.9% and 0.9% for the
three months ended March 31, 2005 and 2006 respectively. No
material changes in estimates have been recognized for the three
months ended March 31, 2005 and 2006.
We record reserves against our inventory to provide for
estimated obsolete or unsalable inventory based on assumptions
about future demand for our products and market conditions. If
future demand and market conditions are less favorable than
managements assumptions, additional reserves could be
required. Likewise, favorable future demand and market
conditions could positively impact future operating results if
previously reserved for inventory is sold. We reserved for
obsolete and slow moving inventory totaling $8.0 million,
and $9.6 million as of December 31, 2005 and
March 31, 2006, respectively.
In accordance with Statement of Financial Accounting Standards
(SFAS) 144, long-lived assets, such as property,
plant, and equipment, and purchased intangibles subject to
amortization, are reviewed for impairment whenever events or
changes in circumstances indicate that the carrying amount of an
asset may not be recoverable. Recoverability of assets to be
held and used is measured by a comparison of the carrying amount
of an asset to estimated undiscounted future cash flows expected
to be generated by the asset. If the carrying amount of an asset
exceeds its estimated future cash flows, an impairment charge is
recognized by the amount by which the carrying amount of the
asset exceeds the fair value of the asset. Assets to be disposed
of would be separately presented in the balance sheet and
reported at the lower of the carrying amount or fair value less
costs to sell, and are no longer depreciated. The assets and
liabilities of a disposed group classified as held for sale
would be presented separately in the appropriate asset and
liability sections of the balance sheet.
Goodwill and other intangibles not subject to amortization are
tested annually for impairment, and are tested for impairment
more frequently if events and circumstances indicate that the
asset might be impaired. An impairment loss is recognized to the
extent that the carrying amount exceeds the assets fair
value. This determination is made at the reporting unit level
and consists of two steps. First, the Company determines the
fair value of a reporting unit and compares it to its carrying
amount.
Second, if the carrying amount of a reporting unit exceeds its
fair value, an impairment loss is recognized for any excess of
the carrying amount of the reporting units goodwill and
other intangibles over the implied fair value. The implied fair
value is determined by allocating the fair value of the
reporting unit in a manner similar to a purchase price
allocation, in accordance with SFAS No. 141,
Business Combinations. The residual fair value after
this allocation is the implied fair value of the reporting unit
goodwill and other intangibles. As of March 31, 2006, we
had goodwill of approximately $129.5 million, and marketing
franchise of $310.0 million. No write-downs have been
recognized for the three months ended March 31, 2005. For
the three months ended March 31, 2006, goodwill was reduced
by $4.7 million due primarily to the effect of the
settlement of an international tax audit related to the
pre-acquisition period.
Contingencies are accounted for in accordance with SFAS 5,
Accounting for Contingencies. SFAS 5 requires
that we record an estimated loss from a loss contingency when
information available prior to issuance of our
26
financial statements indicates that it is probable that an asset
has been impaired or a liability has been incurred at the date
of the financial statements and the amount of the loss can be
reasonably estimated. Accounting for contingencies such as legal
and income tax matters requires us to use judgment. Many of
these legal and tax contingencies can take years to be resolved.
Generally, as the time period increases over which the
uncertainties are resolved, the likelihood of changes to the
estimate of the ultimate outcome increases.
Deferred income tax assets have been established for net
operating loss carryforwards of certain foreign subsidiaries and
have been reduced by a valuation allowance to reflect them at
amounts estimated to be ultimately recognized. The net operating
loss carryforwards expire in varying amounts over a future
period of time. Realization of the income tax carryforwards is
dependent on generating sufficient taxable income prior to
expiration of the carryforwards. Although realization is not
assured, we believe it is more likely than not that the net
carrying value of the income tax carryforwards will be realized.
The amount of the income tax carryforwards that is considered
realizable, however, could change if estimates of future taxable
income during the carryforward period are adjusted.
We account for stock-based compensation in accordance with
SFAS No. 123R, Share-Based
Payment. Under the fair value recognition
provisions of this statement, share-based compensation cost is
measured at the grant date based on the value of the award and
is recognized as expense over the vesting period. Determining
the fair value of share-based awards at the grant date requires
judgment, including estimating out stock price volatility and
employee stock award exercise behaviors. Our expected volatility
is primarily based upon on the historical volatility of
Herbalifes common stock and, but due to the limited period
of public trading data for its common stock, it is also
validated against the volatility of a company peer group. The
expected life of awards is based on observed historical exercise
patterns, which can vary over time. As stock-based compensation
expense recognized in the Consolidated Statement of Income is
based on awards ultimately expected to vest, the amount of
expense has been reduced for estimated forfeitures.
SFAS No. 123R requires forfeitures to be estimated at
the time of grant and revised, if necessary, in subsequent
periods if actual forfeitures differ from those estimates.
Forfeitures were estimated based on historical experience.
New
Accounting Pronouncements
Effective January 1, 2006, we adopted the fair value
recognition provisions of Statement of Financial Accounting
Standards (SFAS) No. 123R, Share-Based Payment
(SFAS No. 123R), which generally requires,
among other things, that all employee share-based compensation
be measured using a fair value method and that the resulting
compensation cost be recognized in the financial statements. We
selected the modified prospective method of adoption. Under this
method, compensation expense that we recognized for the three
months ended March 31, 2006 included: (a) compensation
expense for all share-based payments granted prior to, but not
yet vested as of January 1, 2006, based on the grant date
fair value estimated in accordance with the original provisions
of SFAS No. 123, Accounting for Stock-Based Compensation,
and (b) compensation expense for all share-based payments
granted on or after January 1, 2006, based on the grant
date fair value estimated in accordance with the provisions of
SFAS No. 123R. Results for prior periods were not restated.
See Note 8 to the consolidated financial statements for
more details on stock based compensation.
|
|
Item 3.
|
Quantitative
and Qualitative Disclosures About Market Risk
|
We are exposed to market risks, which arise during the normal
course of business from changes in interest rates and foreign
currency exchange rates. On a selected basis, we use derivative
financial instruments to manage or hedge these risks. All
hedging transactions are authorized and executed pursuant to
written guidelines and procedures.
We have adopted SFAS No. 133, Accounting for
Derivative Instruments and Hedging Activities. SFAS
No. 133, as amended and interpreted, established accounting
and reporting standards for derivative instruments, including
certain derivative instruments embedded in other contracts, and
for hedging activities. All derivatives, whether designated in
hedging relationships or not, are required to be recorded on the
balance sheet at fair value. If the derivative is designated as
a fair-value hedge, the changes in the fair value of the
derivative and the underlying hedged item are recognized
concurrently in earnings. If the derivative is designated as a
cash-flow hedge, changes in the fair value of the derivative are
recorded in other comprehensive income (OCI) and are
recognized in the
27
statement of operations when the hedged item affects earnings.
SFAS No. 133 defined new requirements for designation and
documentation of hedging relationships as well as ongoing
effectiveness assessments in order to use hedge accounting. For
a derivative that does not qualify as a hedge, changes in fair
value are recognized concurrently in earnings.
A discussion of our primary market risk exposures and
derivatives is presented below.
Foreign
Exchange Risk
We enter into foreign exchange derivatives in the ordinary
course of business primarily to reduce exposure to currency
fluctuations attributable to inter-company transactions and
translation of local currency revenue. Most of these foreign
exchange contracts are designated as cash flow hedges for
forecasted transactions.
We purchase average rate put options, which give us the right,
but not the obligation, to sell foreign currency at a specified
exchange rate (strike rate). These contracts provide
protection in the event that the foreign currency weakens beyond
the option strike rate.
The following table provides information about the details of
our option contracts:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Average
|
|
|
Fair
|
|
|
Maturity
|
|
Foreign Currency
|
|
Coverage
|
|
|
Strike Price
|
|
|
Value
|
|
|
Date
|
|
|
|
(In millions)
|
|
|
|
|
|
(In millions)
|
|
|
|
|
|
Purchase Puts (Company may sell
peso/buy USD)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mexican peso
|
|
$
|
19.5
|
|
|
|
10.54 10.82
|
|
|
$
|
0.5
|
|
|
|
Apr-Jun 2006
|
|
Mexican peso
|
|
$
|
19.5
|
|
|
|
10.61 10.86
|
|
|
$
|
0.6
|
|
|
|
Jul-Sep 2006
|
|
Mexican peso
|
|
$
|
18.5
|
|
|
|
10.69 10.94
|
|
|
$
|
0.7
|
|
|
|
Oct-Dec 2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
57.5
|
|
|
|
|
|
|
$
|
1.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchase Puts (Company may sell
real/buy USD)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Brazilian real
|
|
$
|
7.5
|
|
|
|
2.19 2.41
|
|
|
$
|
0.1
|
|
|
|
Apr-Jun 2006
|
|
Brazilian real
|
|
$
|
6.0
|
|
|
|
2.24 2.38
|
|
|
$
|
0.2
|
|
|
|
Jul-Sep 2006
|
|
Brazilian real
|
|
$
|
5.0
|
|
|
|
2.28 2.37
|
|
|
$
|
0.2
|
|
|
|
Oct-Dec 2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
18.5
|
|
|
|
|
|
|
$
|
0.5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchase Puts (Company may sell
won/buy USD)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Korean won
|
|
$
|
3.8
|
|
|
|
972.65 993.80
|
|
|
$
|
0.0
|
|
|
|
Apr-Jun 2006
|
|
Korean won
|
|
$
|
3.8
|
|
|
|
981.50 993.00
|
|
|
$
|
0.1
|
|
|
|
Jul-Sep 2006
|
|
Korean won
|
|
$
|
3.8
|
|
|
|
980.75 992.25
|
|
|
$
|
0.1
|
|
|
|
Oct-Dec 2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
11.4
|
|
|
|
|
|
|
$
|
0.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchase Puts (Company may sell
pounds/buy USD)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
British pound
|
|
$
|
0.8
|
|
|
|
1.785 1.788
|
|
|
$
|
0.0
|
|
|
|
Apr-Jun 2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
0.8
|
|
|
|
|
|
|
$
|
0.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchase Puts (Company may sell
rand/buy USD)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
South African rand
|
|
$
|
1.5
|
|
|
|
6.11 6.13
|
|
|
$
|
0.0
|
|
|
|
Apr-Jun 2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
1.5
|
|
|
|
|
|
|
$
|
0.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchase Puts (Company may sell
Taiwan dollar/buy USD)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Taiwan Dollar
|
|
$
|
2.0
|
|
|
|
31.56 31.78
|
|
|
$
|
0.0
|
|
|
|
Apr-Jun 2006
|
|
Taiwan Dollar
|
|
$
|
2.5
|
|
|
|
31.23 31.39
|
|
|
$
|
0.1
|
|
|
|
Jul-Sep 2006
|
|
Taiwan Dollar
|
|
$
|
3.0
|
|
|
|
30.98 31.25
|
|
|
$
|
0.1
|
|
|
|
Oct-Dec 2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
7.5
|
|
|
|
|
|
|
$
|
0.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
28
Foreign exchange forward contracts are used to hedge advances
between subsidiaries. The objective of these contracts is to
neutralize the impact of foreign currency movements on the
subsidiarys operating results. The fair value of forward
contracts is based on third-party bank quotes.
The following table provides information about the details of
our forward contracts:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Contract
|
|
|
Forward
|
|
|
Maturity
|
|
|
Contract
|
|
|
Fair
|
|
Foreign Currency
|
|
Date
|
|
|
Position
|
|
|
Date
|
|
|
Rate
|
|
|
Value
|
|
|
|
|
|
|
(In millions)
|
|
|
|
|
|
|
|
|
(In millions)
|
|
|
At March 31,
2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Buy USD sell SEK
|
|
|
03/29/06
|
|
|
$
|
2.4
|
|
|
|
04/30/06
|
|
|
|
7.82
|
|
|
$
|
2.4
|
|
Buy USD sell EUR
|
|
|
03/29/06
|
|
|
$
|
0.9
|
|
|
|
04/30/06
|
|
|
|
1.20
|
|
|
$
|
0.9
|
|
Buy USD sell GBP
|
|
|
03/29/06
|
|
|
$
|
3.1
|
|
|
|
04/30/06
|
|
|
|
1.73
|
|
|
$
|
3.1
|
|
Buy TRY sell USD
|
|
|
03/29/06
|
|
|
$
|
3.0
|
|
|
|
04/30/06
|
|
|
|
1.36
|
|
|
$
|
3.0
|
|
Buy KRW sell USD
|
|
|
03/29/06
|
|
|
$
|
6.0
|
|
|
|
04/30/06
|
|
|
|
976.90
|
|
|
$
|
6.0
|
|
Buy JPY sell USD
|
|
|
03/29/06
|
|
|
$
|
4.1
|
|
|
|
04/30/06
|
|
|
|
117.27
|
|
|
$
|
4.1
|
|
Buy CNY sell USD
|
|
|
03/29/06
|
|
|
$
|
5.0
|
|
|
|
04/30/06
|
|
|
|
8.00
|
|
|
$
|
5.0
|
|
Buy INR sell USD
|
|
|
03/29/06
|
|
|
$
|
5.3
|
|
|
|
04/30/06
|
|
|
|
44.81
|
|
|
$
|
5.3
|
|
Buy TRY sell USD
|
|
|
03/30/06
|
|
|
$
|
1.1
|
|
|
|
04/27/06
|
|
|
|
1.36
|
|
|
$
|
1.1
|
|
Buy EUR sell USD
|
|
|
03/29/06
|
|
|
$
|
15.9
|
|
|
|
04/30/06
|
|
|
|
1.20
|
|
|
$
|
16.0
|
|
Buy USD sell EUR
|
|
|
03/29/06
|
|
|
$
|
10.8
|
|
|
|
04/30/06
|
|
|
|
1.20
|
|
|
$
|
10.9
|
|
Buy USD sell EUR
|
|
|
03/31/06
|
|
|
$
|
13.4
|
|
|
|
04/30/06
|
|
|
|
1.21
|
|
|
$
|
13.3
|
|
Buy EUR sell USD
|
|
|
03/29/06
|
|
|
$
|
12.1
|
|
|
|
04/30/06
|
|
|
|
1.21
|
|
|
$
|
12.1
|
|
Buy CAD sell EUR
|
|
|
03/29/06
|
|
|
$
|
1.6
|
|
|
|
04/30/06
|
|
|
|
1.41
|
|
|
$
|
1.547
|
|
Buy NZD sell EUR
|
|
|
03/29/06
|
|
|
$
|
0.6
|
|
|
|
04/30/06
|
|
|
|
1.99
|
|
|
$
|
0.616
|
|
Buy TWD sell EUR
|
|
|
03/28/06
|
|
|
$
|
5.0
|
|
|
|
04/30/06
|
|
|
|
39.16
|
|
|
$
|
5.028
|
|
Buy NOK sell EUR
|
|
|
03/29/06
|
|
|
$
|
1.5
|
|
|
|
04/30/06
|
|
|
|
7.98
|
|
|
$
|
1.533
|
|
Buy DKK sell EUR
|
|
|
03/29/06
|
|
|
$
|
1.3
|
|
|
|
04/30/06
|
|
|
|
7.46
|
|
|
$
|
1.305
|
|
Buy PLN sell EUR
|
|
|
03/29/06
|
|
|
$
|
0.8
|
|
|
|
04/30/06
|
|
|
|
3.95
|
|
|
$
|
0.776
|
|
Buy EUR sell USD
|
|
|
03/29/06
|
|
|
$
|
17.5
|
|
|
|
04/30/06
|
|
|
|
1.21
|
|
|
$
|
17.6
|
|
Buy USD sell EUR
|
|
|
03/29/06
|
|
|
$
|
0.8
|
|
|
|
04/30/06
|
|
|
|
1.20
|
|
|
$
|
0.8
|
|
Buy HUF sell EUR
|
|
|
03/29/06
|
|
|
$
|
0.9
|
|
|
|
04/30/06
|
|
|
|
266.91
|
|
|
$
|
0.9
|
|
Buy EUR sell HUF
|
|
|
03/30/06
|
|
|
$
|
0.2
|
|
|
|
04/30/06
|
|
|
|
265.63
|
|
|
$
|
0.2
|
|
Buy EUR sell USD
|
|
|
03/29/06
|
|
|
$
|
12.9
|
|
|
|
04/30/06
|
|
|
|
1.20
|
|
|
$
|
13.0
|
|
Buy EUR sell SEK
|
|
|
03/29/06
|
|
|
$
|
0.6
|
|
|
|
04/30/06
|
|
|
|
9.42
|
|
|
$
|
0.6
|
|
Buy YEN sell CHF
|
|
|
03/29/06
|
|
|
$
|
22.8
|
|
|
|
04/30/06
|
|
|
|
89.80
|
|
|
$
|
22.7
|
|
Buy EUR sell GBP
|
|
|
03/29/06
|
|
|
$
|
0.8
|
|
|
|
04/30/06
|
|
|
|
0.69
|
|
|
$
|
0.9
|
|
All our foreign subsidiaries, excluding those operating in
hyper-inflationary environments, designate their local
currencies as their functional currency. At March 31, 2006,
the total amount of our foreign subsidiary cash was
71.7 million, of which $2.0 million was invested in
U.S. dollars.
29
Interest
Rate Risk
We use interest rate swaps to hedge the interest rate exposure
on the variable interest rate associated with our senior credit
facility. They provide protection in the event the LIBOR rates
fluctuate. Interest rate swaps are designated as cash flow
hedges. The table below describes the interest rate swap that
was outstanding:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
National
|
|
Average
|
|
Fair
|
|
Maturity
|
Interest Rate
|
|
Amount
|
|
Rate
|
|
Value
|
|
Date
|
|
|
(In millions)
|
|
|
|
(In millions)
|
|
|
|
At March 31,
2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate swap
|
|
$
|
20.0
|
|
|
|
4.27%
|
|
|
$
|
0.33
|
|
|
|
01/28/2008
|
|
The table below presents principal cash flows and interest rates
by maturity dates and the fair values of our borrowings as of
March 31, 2006. Fair values for fixed rate borrowings have
been determined based on recent market trade values. The fair
values for variable rate borrowings approximate their carrying
value. Variable interest rates disclosed represent the rates on
the borrowings at March 31, 2006. Interest rate risk
related to our capital leases is not significant.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected Maturity Date
|
|
|
|
2006
|
|
|
2007
|
|
|
2008
|
|
|
2009
|
|
|
2010
|
|
|
Thereafter
|
|
|
Total
|
|
|
Fair Value
|
|
|
Long-term Debt
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed Rate (in millions)
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
0.1
|
|
|
$
|
|
|
|
$
|
0.1
|
|
|
$
|
0.1
|
|
Average Interest Rate
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11.75
|
%
|
|
|
|
|
Variable Rate (in millions)
|
|
$
|
0.6
|
|
|
$
|
0.8
|
|
|
$
|
0.8
|
|
|
$
|
0.8
|
|
|
$
|
76.8
|
|
|
$
|
|
|
|
$
|
79.8
|
|
|
$
|
79.8
|
|
Average Interest Rate
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6.46
|
%
|
|
|
|
|
Fixed Rate (in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
165.0
|
|
|
$
|
165.0
|
|
|
$
|
176.6
|
|
Average Interest Rate
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9.5
|
%
|
|
|
|
|
Under the $200.0 million term loan, the Company is
obligated to enter into (for a minimum of three years after
December 21, 2004) an interest rate hedge for up to
25% of the aggregate principal amount of the term loan. On
February 24, 2005 the Company entered into an interest rate
swap, as discussed above, to fulfill this obligation.
|
|
Item 4.
|
Controls
And Procedures
|
Evaluation of Disclosure Controls and
Procedures. Our management, including our Chief
Executive Officer and Chief Financial Officer, has evaluated the
effectiveness of our disclosure controls and procedures (as such
term is defined in
Rules 13a-15(e)
and
15d-15(e)
under the Securities Exchange Act of 1934, as amended (the
Exchange Act)), as of the end of the period covered
by this report. Based on such evaluation, our Chief Executive
Officer and Chief Financial Officer have concluded that our
disclosure controls and procedures were effective as of the end
of the period covered by this report.
Changes in Internal Control Over Financial
Reporting. There were no changes in our internal
control over financial reporting (as such term is defined in
Rules 13a-15(f)
and
15d-15(f)
under the Exchange Act) that occurred during the last fiscal
quarter that have materially affected, or are reasonably likely
to materially affect, our internal control over financial
reporting.
FORWARD
LOOKING STATEMENTS
This document contains forward-looking statements
within the meaning of Section 27A of the Securities Act of
1933, as amended and Section 21E of the Securities Exchange
Act of 1934, as amended. All statements other than statements of
historical fact are forward-looking statements for
purposes of federal and state securities laws, including any
projections of earnings, revenue or other financial items; any
statements of the plans, strategies and objectives of management
for future operations; any statements concerning proposed new
services or developments; any statements regarding future
economic conditions or performance; any statements of belief;
and any statements of assumptions underlying any of the
foregoing. Forward-looking statements may include the words
may, will, estimate,
intend, continue, believe,
expect or anticipate and other similar
words.
30
Although we believe that the expectations reflected in any of
our forward-looking statements are reasonable, actual results
could differ materially from those projected or assumed in any
of our forward-looking statements. Our future financial
condition and results of operations, as well as any
forward-looking statements, are subject to change and to
inherent risks and uncertainties, such as those disclosed in
this document. Important factors that could cause our actual
results, performance and achievements, or industry results to
differ materially from estimates or projections contained in our
forward-looking statements include, among others, the
following:
|
|
|
|
|
our relationship with, and our ability to influence the
actions of, our distributors;
|
|
|
|
adverse publicity associated with our products or network
marketing organization;
|
|
|
|
uncertainties relating to interpretation and enforcement of
recently enacted legislation in China governing direct
selling;
|
|
|
|
adverse changes in the Chinese economy, Chinese legal system
or Chinese governmental policies;
|
|
|
|
risk of improper action by Chinese employees or international
distributors in violation of Chinese law;
|
|
|
|
changing consumer preferences and demands;
|
|
|
|
the competitive nature of our business;
|
|
|
|
regulatory matters governing our products, including
potential governmental or regulatory actions concerning the
safety or efficacy of our products, and network marketing
program;
|
|
|
|
risks associated with operating internationally, including
foreign exchange risks;
|
|
|
|
our dependence on increased penetration of existing
markets;
|
|
|
|
contractual limitations on our ability to expand our
business;
|
|
|
|
our reliance on our information technology infrastructure and
outside manufacturers;
|
|
|
|
the sufficiency of trademarks and other intellectual property
rights;
|
|
|
|
product concentration;
|
|
|
|
our reliance on our management team;
|
|
|
|
uncertainties relating to the application of transfer pricing
and similar tax regulations;
|
|
|
|
taxation relating to our distributors; and
|
|
|
|
product liability claims.
|
Additional factors that could cause actual results to differ
materially from our forward-looking statements are set forth in
this Quarterly Report on
Form 10-Q,
including under the heading Risk Factors,
Managements Discussion and Analysis of Financial
Condition and Results of Operations and in our Financial
Statements and the related notes.
Forward-looking statements in this Quarterly Report on
Form 10-Q
speak only as of the date hereof, and forward looking statements
in documents attached are incorporated by reference speak only
as of the date of those documents. The Company does not
undertake any obligation to update or release any revisions to
any forward-looking statement or to report any events or
circumstances after the date hereof or to reflect the occurrence
of unanticipated events, except as required by law.
PART II.
OTHER INFORMATION
|
|
Item 1.
|
LEGAL
PROCEEDINGS
|
See discussion under Note 5 to the Notes to the Condensed
Consolidated Financial Statements included in Item 1 of
this report.
31
Our
failure to establish and maintain distributor relationships for
any reason could negatively impact sales of our products and
harm our financial condition and operating
results.
We distribute our products exclusively through over one million
independent distributors, and we depend upon them directly for
substantially all of our sales. To increase our revenue, we must
increase the number of, or the productivity of, our
distributors. Accordingly, our success depends in significant
part upon our ability to recruit, retain and motivate a large
base of distributors. There is a high rate of turnover among our
distributors, a characteristic of the network marketing
business. The loss of a significant number of distributors for
any reason could negatively impact sales of our products and
could impair our ability to attract new distributors. In our
efforts to attract and retain distributors, we compete with
other network marketing organizations, including those in the
weight management product, dietary and nutritional supplement
and personal care and cosmetic product industries. Our operating
results could be harmed if our existing and new business
opportunities and products do not generate sufficient interest
to retain existing distributors and attract new distributors.
In light of the high
year-over-year
rate of turnover in our distributor base, we have our
supervisors requalify annually in order to help us maintain a
more accurate count of their numbers. For the latest twelve
month re-qualification period ending January 2006, 41.5% of our
supervisors re-qualified. Distributors who purchase our product
for personal consumption or for short-term income goals may stay
with us for several months to one year. Supervisors who have
committed time and effort to build a sales organization will
generally stay for longer periods. Distributors have highly
variable levels of training, skills and capabilities. The
turnover rate of our distributors, and our operating results,
can be adversely impacted if we and our senior distributor
leadership do not provide the necessary mentoring, training and
business support tools for new distributors to become successful
sales people in a short period of time.
We estimate that, of our over one million independent
distributors, we had approximately 244,000 supervisors after
requalifications in February 2006. These supervisors, together
with their downline sales organizations, account for
substantially all of our revenues. Our distributors, including
our supervisors, may voluntarily terminate their distributor
agreements with us at any time. The loss of a group of leading
supervisors, together with their downline sales organizations,
or the loss of a significant number of distributors for any
reason, could negatively impact sales of our products, impair
our ability to attract new distributors and harm our financial
condition and operating results.
Since
we cannot exert the same level of influence or control over our
independent distributors as we could were they our own
employees, our distributors could fail to comply with our
distributor policies and procedures, which could result in
claims against us that could harm our financial condition and
operating results.
Our distributors are independent contractors and, accordingly,
we are not in a position to directly provide the same direction,
motivation and oversight as we would if distributors were our
own employees. As a result, there can be no assurance that our
distributors will participate in our marketing strategies or
plans, accept our introduction of new products, or comply with
our distributor policies and procedures.
Extensive federal, state and local laws regulate our business,
our products and our network marketing program. Because we have
expanded into foreign countries, our policies and procedures for
our independent distributors differ due to the different legal
requirements of each country in which we do business. While we
have implemented distributor policies and procedures designed to
govern distributor conduct and to protect the goodwill
associated with Herbalife trademarks and tradenames, it can be
difficult to enforce these policies and procedures because of
the large number of distributors and their independent status.
Violations by our distributors of applicable law or of our
policies and procedures in dealing with customers could reflect
negatively on our products and operations, and harm our business
reputation. In addition, it is possible that a court could hold
us civilly or criminally accountable based on vicarious
liability because of the actions of our independent
distributors. If any of these events occur, the value of an
investment in our common shares could be impaired. For example,
in Mey v. Herbalife International, et al, the plaintiff
seeks to hold the Company vicariously liable for actions of
certain of its distributors, each of whom is an independent
contractor. While the Company vigorously denies such
distributors were acting as agents of the
32
Company, and although the court specifically did not rule on the
question of vicarious liability, on April 21, 2006 it did
grant the plaintiffs motion to certify the case as a class
action. We believe that we have meritorious defenses and will
continue to vigorously defend this lawsuit.
Adverse
publicity associated with our products, ingredients or network
marketing program, or those of similar companies, could harm our
financial condition and operating results.
The size of our distribution force and the results of our
operations may be significantly affected by the publics
perception of our Company and similar companies. This perception
is dependent upon opinions concerning:
|
|
|
|
|
the safety and quality of our products and ingredients;
|
|
|
|
the safety and quality of similar products and ingredients
distributed by other companies;
|
|
|
|
our distributors;
|
|
|
|
our network marketing program; and
|
|
|
|
the direct selling business generally.
|
Adverse publicity concerning any actual or purported failure of
our Company or our distributors to comply with applicable laws
and regulations regarding product claims and advertising, good
manufacturing practices, the regulation of our network marketing
program, the licensing of our products for sale in our target
markets or other aspects of our business, whether or not
resulting in enforcement actions or the imposition of penalties,
could have an adverse effect on the goodwill of our Company and
could negatively affect our ability to attract, motivate and
retain distributors, which would negatively impact our ability
to generate revenue. We cannot ensure that all distributors will
comply with applicable legal requirements relating to the
advertising, labeling, licensing or distribution of our products.
In addition, our distributors and consumers
perception of the safety and quality of our products and
ingredients as well as similar products and ingredients
distributed by other companies can be significantly influenced
by national media attention, publicized scientific research or
findings, widespread product liability claims and other
publicity concerning our products or ingredients or similar
products and ingredients distributed by other companies. Adverse
publicity, whether or not accurate or resulting from
consumers use or misuse of our products, that associates
consumption of our products or ingredients or any similar
products or ingredients with illness or other adverse effects,
questions the benefits of our or similar products or claims that
any such products are ineffective, inappropriately labeled or
have inaccurate instructions as to their use, could negatively
impact our reputation or the market demand for our products.
Adverse publicity relating to us, our products or our
operations, including our network marketing program or the
attractiveness or viability of the financial opportunities
provided thereby, has had, and could again have, a negative
effect on our ability to attract, motivate and retain
distributors. In the mid-1980s, our products and marketing
program became the subject of regulatory scrutiny in the United
States, resulting in large part from claims and representations
made about our products by our distributors, including
impermissible therapeutic claims. The resulting adverse
publicity caused a rapid, substantial loss of distributors in
the United States and a corresponding reduction in sales
beginning in 1985. We expect that negative publicity will, from
time to time, continue to negatively impact our business in
particular markets.
Our
failure to appropriately respond to changing consumer
preferences and demand for new products or product enhancements
could significantly harm our distributor and customer
relationships and product sales and harm our financial condition
and operating results and cause the loss or reduction in the
value of your investment in our common shares.
Our business is subject to changing consumer trends and
preferences, especially with respect to weight management
products. Our continued success depends in part on our ability
to anticipate and respond to these changes, and we may not
respond in a timely or commercially appropriate manner to such
changes. Furthermore, the nutritional supplement industry is
characterized by rapid and frequent changes in demand for
products and new product introductions and enhancements. Our
failure to accurately predict these trends could negatively
impact
33
consumer opinion of our products, which in turn could harm our
customer and distributor relationships and cause the loss of
sales. The success of our new product offerings and enhancements
depends upon a number of factors, including our ability to:
|
|
|
|
|
accurately anticipate customer needs;
|
|
|
|
innovate and develop new products or product enhancements that
meet these needs;
|
|
|
|
successfully commercialize new products or product enhancements
in a timely manner;
|
|
|
|
price our products competitively;
|
|
|
|
manufacture and deliver our products in sufficient volumes and
in a timely manner; and
|
|
|
|
differentiate our product offerings from those of our
competitors.
|
If we do not introduce new products or make enhancements to meet
the changing needs of our customers in a timely manner, some of
our products could be rendered obsolete, which could negatively
impact our revenues, financial condition and operating results.
Due to
the high level of competition in our industry, we might fail to
retain our customers and distributors, which would harm our
financial condition and operating results.
The business of marketing weight management and nutrition
products is highly competitive and sensitive to the introduction
of new products or weight management plans, including various
prescription drugs, which may rapidly capture a significant
share of the market. These market segments include numerous
manufacturers, distributors, marketers, retailers and physicians
that actively compete for the business of consumers both in the
United States and abroad. In addition, we anticipate that we
will be subject to increasing competition in the future from
sellers that utilize electronic commerce. Some of these
competitors have longer operating histories, significantly
greater financial, technical, product development, marketing and
sales resources, greater name recognition, larger established
customer bases and better-developed distribution channels than
we do. Our present or future competitors may be able to develop
products that are comparable or superior to those we offer,
adapt more quickly than we do to new technologies, evolving
industry trends and standards or customer requirements, or
devote greater resources to the development, promotion and sale
of their products than we do. For example, if our competitors
develop other diet or weight loss treatments that prove to be
more effective than our products, demand for our products could
be reduced. Accordingly, we may not be able to compete
effectively in our markets and competition may intensify.
We are also subject to significant competition for the
recruitment of distributors from other network marketing
organizations, including those that market weight management
products, dietary and nutritional supplements and personal care
products as well as other types of products. We compete for
global customers and distributors with regard to weight
management, nutritional supplement and personal care products.
Our competitors include both direct selling companies such as
NuSkin Enterprises, Natures Sunshine, Alticor/Amway,
Melaleuca, Avon Products, Oriflame, and Mary Kay, as well as
retail establishments such as Weight Watchers, Jenny Craig,
General Nutrition Centers, Wal-Mart and retail pharmacies. In
addition, because the industry in which we operate is not
particularly capital intensive or otherwise subject to high
barriers to entry, it is relatively easy for new competitors to
emerge who will compete with us for our distributors and
customers. In addition, the fact that our distributors may
easily enter and exit our network marketing program contributes
to the level of competition that we face. For example, a
distributor can enter or exit our network marketing system with
relative ease at any time without facing a significant
investment or loss of capital because (1) we have a low
upfront financial cost (generally $50 to $75) to become a
Herbalife distributor, (2) we do not require any specific
amount of time to work as a distributor, (3) we do not
insist on any special training to be a distributor and
(4) we do not prohibit a new distributor from working with
another company. Our ability to remain competitive therefore
depends, in significant part, on our success in recruiting and
retaining distributors through an attractive compensation plan,
the maintenance of an attractive product portfolio and other
incentives. We cannot ensure that our programs for recruitment
and retention of distributors will be successful, and if they
are not, our financial condition and operating results would be
harmed.
34
We are
affected by extensive laws, governmental regulations,
administrative determinations, court decisions and similar
constraints both domestically and abroad and our failure or our
distributors failure to comply with these restraints could
lead to the imposition of significant penalties or claims, which
could harm our financial condition and operating
results.
In both domestic and foreign markets, the formulation,
manufacturing, packaging, labeling, distribution, importation,
exportation, licensing, sale and storage of our products are
affected by extensive laws, governmental regulations,
administrative determinations, court decisions and similar
constraints. Such laws, regulations and other constraints may
exist at the federal, state or local levels in the United States
and at all levels of government in foreign jurisdictions. There
can be no assurance that we or our distributors are in
compliance with all of these regulations. Our failure or our
distributors failure to comply with these regulations or
new regulations could lead to the imposition of significant
penalties or claims and could negatively impact our business. In
addition, the adoption of new regulations or changes in the
interpretations of existing regulations may result in
significant compliance costs or discontinuation of product sales
and may negatively impact the marketing of our products,
resulting in significant loss of sales revenues. For example,
the Food and Drug Administration, or the FDA, has announced
plans to issue new guidance or regulations relating to low
carbohydrate claims for foods, which could negatively impact our
sales of such products.
Governmental regulations in countries where we plan to commence
or expand operations may prevent or delay entry into those
markets. In addition, our ability to sustain satisfactory levels
of sales in our markets is dependent in significant part on our
ability to introduce additional products into such markets.
However, governmental regulations in our markets, both domestic
and international, can delay or prevent the introduction, or
require the reformulation or withdrawal, of certain of our
products. For example, during the third quarter of 1995, we
received inquiries from certain governmental agencies within
Germany and Portugal regarding our product,
Thermojetics®
Instant Herbal Beverage, relating to the caffeine content of
the product and the status of the product as an instant
tea, which was disfavored by regulators, versus a
beverage. Although we initially suspended the
product sale in Germany and Portugal at the request of the
regulators, we successfully reintroduced it once regulatory
issues were satisfactorily resolved. Any such regulatory action,
whether or not it results in a final determination adverse to
us, could create negative publicity, with detrimental effects on
the motivation and recruitment of distributors and,
consequently, on sales.
On March 7, 2003, the FDA proposed a new regulation to
require current good manufacturing practices affecting the
manufacture, packing, and holding of dietary supplements. The
proposed regulation would establish standards to ensure that
dietary supplements and dietary ingredients are not adulterated
with contaminants or impurities, and are labeled to accurately
reflect the active ingredients and other ingredients in the
products. It also includes proposed requirements for designing
and constructing physical plants, establishing quality control
procedures, and testing manufactured dietary ingredients and
dietary supplements, as well as proposed requirements for
maintaining records and for handling consumer complaints related
to cGMPs. We are evaluating this proposal with respect to its
potential impact upon the various contract manufacturers that we
use to manufacturer our products, some of whom might not meet
the new standards. It is important to note that the proposed
regulation, in an effort to limit disruption, includes a
three-year phase-in for small businesses of any final regulation
that is issued. This will mean that some of our contract
manufacturers will not be fully impacted by the proposed
regulation until at least 2008. However, the proposed regulation
can be expected to result in additional costs and possibly the
need to seek alternate suppliers.
Our
network marketing program could be found to be not in compliance
with current or newly adopted laws or regulations in one or more
markets, which could prevent us from conducting our business in
these markets and harm our financial condition and operating
results.
Our network marketing program is subject to a number of federal
and state regulations administered by the Federal Trade
Commission and various state agencies in the United States as
well as regulations on direct selling in foreign markets
administered by foreign agencies. We are subject to the risk
that, in one or more markets, our network marketing program
could be found not to be in compliance with applicable law or
regulations. Regulations applicable to network marketing
organizations generally are directed at preventing fraudulent or
deceptive schemes, often referred to as pyramid or
chain sales schemes, by ensuring that product sales
ultimately
35
are made to consumers and that advancement within an
organization is based on sales of the organizations
products rather than investments in the organization or other
non-retail sales-related criteria. The regulatory requirements
concerning network marketing programs do not include
bright line rules and are inherently fact-based, and
thus, even in jurisdictions where we believe that our network
marketing program is in full compliance with applicable laws or
regulations governing network marketing systems, we are subject
to the risk that these laws or regulations or the enforcement or
interpretation of these laws and regulations by governmental
agencies or courts can change. The failure of our network
marketing program to comply with current or newly adopted
regulations could negatively impact our business in a particular
market or in general.
We are also subject to the risk of private party challenges to
the legality of our network marketing program. The multi-level
marketing programs of other companies have been successfully
challenged in the past, and in a current lawsuit, allegations
have been made challenging the legality of our network marketing
program in Belgium. Test Ankoop-Test Achat, a Belgian consumer
protection organization, sued Herbalife International Belgium,
S.V., or HIB, on August 26, 2004, alleging that HIB
violated Article 84 of the Belgian Fair Trade Practices Act
by engaging in pyramid selling, i.e., establishing a
network of professional or non-professional sales people who
hope to make a profit more through the expansion of that network
rather than through the sale of products to end-consumers. The
plaintiff is seeking a payment of 25,000 (equal to
approximately $30,000 as of March 31, 2006) per
purported violation as well as costs of the trial. For the year
ended December 31, 2005, our net sales in Belgium were
approximately $15.9 million. Currently, the lawsuit is in
the pleading stage. The plaintiffs filed their initial brief on
September 27, 2005. An adverse judicial determination with
respect to our network marketing program, or in proceedings not
involving us directly but which challenge the legality of
multi-level marketing systems, in Belgium or in any other market
in which we operate, could negatively impact our business.
A
substantial portion of our business is conducted in foreign
markets, exposing us to the risks of trade or foreign exchange
restrictions, increased tariffs, foreign currency fluctuations
and similar risks associated with foreign
operations.
Approximately 82% of our net sales for the three months ended
March 31, 2006, were generated outside the
United States, exposing our business to risks associated
with foreign operations. For example, a foreign government may
impose trade or foreign exchange restrictions or increased
tariffs, which could negatively impact our operations. We are
also exposed to risks associated with foreign currency
fluctuations. For instance, purchases from suppliers are
generally made in U.S. dollars while sales to distributors
are generally made in local currencies. Accordingly,
strengthening of the U.S. dollar versus a foreign currency
could have a negative impact on us. Although we engage in
transactions to protect against risks associated with foreign
currency fluctuations, we cannot be certain any hedging activity
will effectively reduce our exchange rate exposure. Our
operations in some markets also may be adversely affected by
political, economic and social instability in foreign countries.
As we continue to focus on expanding our existing international
operations, these and other risks associated with international
operations may increase, which could harm our financial
condition and operating results.
Our
expansion in China is subject to general, as well as
industry-specific, economic, political and legal developments in
China, and requires that we utilize a different business model
from that we use elsewhere in the world.
Our expansion of operations into China is subject to risks and
uncertainties related to general economic, political and legal
developments in China, among other things. The Chinese
government exercises significant control over the Chinese
economy, including but not limited to controlling capital
investments, allocating resources, setting monetary policy,
controlling foreign exchange and monitoring foreign exchange
rates, implementing and overseeing tax regulations and providing
preferential treatment to certain industry segments or
companies. Accordingly, any adverse change in the Chinese
economy, the Chinese legal system or Chinese governmental,
economic or other policies could have a material adverse effect
on our business in China.
In August 2005, China published regulations governing direct
selling (effective December 1, 2005) and prohibiting
pyramid promotional schemes (effective November 1,
2005) and a number of administrative methods and
proclamations were issued in proposal form in September 2005.
When final, effective and applicable to us, these regulations
will require us to use a business model different from that
which we offer in other markets. To
36
allow us to operate in advance of the effectiveness of these new
regulations, as well as to operate once those regulations are
implemented, we have created and introduced a model specifically
for China. In China, we have Company-operated retail stores that
sell through employed sales management personnel to customers
and preferred customers. We provide training and certification
procedures for sales personnel in China. Once the regulations
are effective, we also expect to sell through independent direct
sellers. These features are not common to the business model we
employ elsewhere in the world. The direct selling regulations
require us to apply for approval to conduct a direct selling
enterprise in China. There can be no assurance that we will be
able to obtain that license. Additionally, although certain
regulations have been published, others are pending, and there
is uncertainty regarding the interpretation and enforcement of
such regulations. The regulatory environment in China is
evolving, and officials in the Chinese government often exercise
discretion in deciding how to interpret and apply regulations.
As such, we have worked closely with governmental agencies and
advisors in interpreting both the existing regulations and the
new regulations. However, we cannot be certain that our business
model will be deemed by national or local Chinese regulatory
authorities to be compliant with these or other more general
regulations. In the past, the Chinese government has rigorously
monitored the direct selling market in China, and has taken
serious action against companies that the government believed
were engaging in activities they regarded to be in violation of
applicable law, including shutting down their businesses and
imposing substantial fines. As a result, there can be no
guarantee that the Chinese governments interpretation and
application of the existing and new regulations will not
negatively impact our business in China, result in regulatory
investigations or lead to fines or penalties.
Chinese regulations prevent persons who are not Chinese
nationals from engaging in direct selling in China. We cannot
guarantee that any of our distributors living outside of China
or any of our independent sales representatives or employed
sales management personnel in China will not engage in
activities that violate our policies in this market and
therefore result in regulatory action and adverse publicity.
As we expand operations in China, we anticipate that certain
distributors will switch their focus from their home markets to
that of China. As a result, we may see reduced distributor focus
in Hong Kong, Taiwan and possibly other of our markets as
Chinese nationals that are distributors shift their attention to
China, and a resultant reduction in distributor growth,
leadership and revenue in these other countries.
If our operations in China are successful, we may experience
rapid growth in China, and there can be no assurances that we
will be able to successfully manage rapid expansion of
manufacturing operations and a rapidly growing and dynamic sales
force. There also can be no assurances that we will not
experience difficulties in dealing with or taking employment
related actions (such as hiring, terminations and salary
administration, including social benefit payments) with respect
to our employed sales representatives, particularly given the
highly regulated nature of the employment relationship in China.
If we are unable to effectively manage such growth and expansion
of our retail stores, manufacturing operations or our employees,
our government relations may be compromised and our operations
in China may be harmed.
Our China business model, particularly with regard to sales
management responsibilities and remuneration, differs from our
traditional business model. There is a risk that such changes
and transitions may not be understood by our distributors or
employees, may be viewed negatively by our distributors or
employees, or may not be correctly utilized by our distributors
or employees. If that is the case, our business could be
negatively impacted.
If we
fail to further penetrate existing markets or successfully
expand our business into new markets, then the growth in sales
of our products, along with our operating results, could be
negatively impacted and investors could lose all or part of
their investment in our common shares.
The success of our business is to a large extent contingent on
our ability to continue to grow by entering new markets and
further penetrating existing markets. Our ability to further
penetrate existing markets in which we compete or to
successfully expand our business into additional countries in
Eastern Europe, Southeast Asia, South America or elsewhere, to
the extent we believe that we have identified attractive
geographic expansion opportunities in the future, is subject to
numerous factors, many of which are out of our control.
In addition, government regulations in both our domestic and
international markets can delay or prevent the introduction, or
require the reformulation or withdrawal, of some of our
products, which could negatively impact our business, financial
condition and results of operations. Also, our ability to
increase market penetration in certain
37
countries may be limited by the finite number of persons in a
given country inclined to pursue a direct selling business
opportunity. Moreover, our growth will depend upon improved
training and other activities that enhance distributor retention
in our markets. We cannot assure you that our efforts to
increase our market penetration and distributor retention in
existing markets will be successful. Thus, if we are unable to
continue to expand into new markets or further penetrate
existing markets, our operating results would suffer and the
market value of our common shares could decline.
Our
contractual obligation to sell our products only through our
Herbalife distributor network and to refrain from changing
certain aspects of our marketing plan may limit our
growth.
In connection with the Acquisition, we entered into an agreement
with our distributors that provided assurances that the change
in ownership of our Company would not negatively affect certain
aspects of their business. Through this agreement, we have
committed to our distributors that we will not sell Herbalife
products through any distribution channel other than our network
of independent Herbalife distributors. Thus, we are
contractually prohibited from expanding our business by selling
Herbalife products through other distribution channels that may
be available to our competitors, such as over the internet,
through wholesale sales, by establishing retail stores or
through mail order systems. Since this is an ongoing or
open-ended commitment, there can be no assurance that we will be
able to take advantage of innovative new distribution channels
that are developed in the future.
In addition, our agreement with our distributors provides that
we will not change certain aspects of our marketing plan without
the consent of a specified percentage of our distributors. For
example, our agreement with our distributors provides that we
may increase, but not decrease, the discount percentages
available to our distributors for the purchase of products or
the applicable royalty override percentages, including roll-ups,
and production and other bonus percentages available to our
distributors at various qualification levels within our
distributor hierarchy. We may not modify the eligibility or
qualification criteria for these discounts, royalty overrides
and production and other bonuses unless we do so in a manner to
make eligibility
and/or
qualification easier than under the applicable criteria in
effect as of the date of the agreement. Our agreement with our
distributors further provides that we may not vary the criteria
for qualification for each distributor tier within our
distributor hierarchy, unless we do so in such a way so as to
make qualification easier.
Although we reserved the right to make these changes to our
marketing plan without the consent of our distributors in the
event that changes are required by applicable law or are
necessary in our reasonable business judgment to account for
specific local market or currency conditions to achieve a
reasonable profit on operations, there can be no assurance that
our agreement with our distributors will not restrict our
ability to adapt our marketing plan to the evolving requirements
of the markets in which we operate. As a result, our growth, and
the potential of growth in the value of your investment in our
common shares, may be limited.
We
depend on the integrity and reliability of our information
technology infrastructure, and any related inadequacies may
result in substantial interruptions to our
business.
Our ability to timely provide products to our distributors and
their customers, and services to our distributors, depends on
the integrity of our information technology system, which we are
in the process of upgrading, including the reliability of
software and services supplied by our vendors. We are
implementing an Oracle enterprise-wide technology solution, a
scalable and stable open architecture platform, to enhance our
and our distributors efficiency and productivity. In
addition, we are upgrading our internet-based marketing and
distributor services platform, MyHerbalife.com. We
expect these initiatives to be substantially complete by 2008.
The most important aspect of our information technology
infrastructure is the system through which we record and track
distributor sales, volume points, royalty overrides, bonuses and
other incentives. We have encountered, and may encounter in the
future, errors in our software or our enterprise network, or
inadequacies in the software and services supplied by our
vendors, although to date none of these errors or inadequacies
has had a meaningful negative impact on our business. Any such
errors or inadequacies that we may encounter in the future may
result in substantial interruptions to our services and may
damage our relationships with, or cause us to lose, our
distributors if the errors or inadequacies impair our ability to
track sales and pay royalty overrides, bonuses and other
incentives,
38
which would harm our financial condition and operating results.
Such errors may be expensive or difficult to correct in a timely
manner, and we may have little or no control over whether any
inadequacies in software or services supplied to us by third
parties are corrected, if at all.
Since
we rely on independent third parties for the manufacture and
supply of our products, if these third parties fail to reliably
supply products to us at required levels of quality, then our
financial condition and operating results would be
harmed.
All of our products are manufactured by outside companies,
except for a small amount of products manufactured in our own
manufacturing facility in China. We cannot assure you that our
outside manufacturers will continue to reliably supply products
to us at the levels of quality, or the quantities, we require,
especially after the FDA imposes cGMPs regulations.
Our supply contracts generally have a two-year term. Except for
force majeure events, such as natural disasters and other acts
of God, and non-performance by Herbalife, our manufacturers
generally cannot unilaterally terminate these contracts. These
contracts can generally be extended by us at the end of the
relevant time period and we have exercised this right in the
past. Globally we have over 40 suppliers of our products. For
our major products, we have both primary and secondary
suppliers. Our major suppliers include Natures Bounty for
protein powders, Fine Foods (Italy) for protein powders and
nutritional supplements, PharmaChem Labs for teas and
Niteworkstm
and JB Labs for fiber. In the event any of our third-party
manufacturers were to become unable or unwilling to continue to
provide us with products in required volumes and at suitable
quality levels, we would be required to identify and obtain
acceptable replacement manufacturing sources. There is no
assurance that we would be able to obtain alternative
manufacturing sources on a timely basis. An extended
interruption in the supply of products would result in the loss
of sales. In addition, any actual or perceived degradation of
product quality as a result of reliance on third party
manufacturers may have an adverse effect on sales or result in
increased product returns and buybacks.
If we
fail to protect our trademarks and tradenames, then our ability
to compete could be negatively affected, which would harm our
financial condition and operating results.
The market for our products depends to a significant extent upon
the goodwill associated with our trademark and tradenames. We
own, or have licenses to use, the material trademark and trade
name rights used in connection with the packaging, marketing and
distribution of our products in the markets where those products
are sold. Therefore, trademark and trade name protection is
important to our business. Although most of our trademarks are
registered in the United States and in certain foreign countries
in which we operate, we may not be successful in asserting
trademark or trade name protection. In addition, the laws of
certain foreign countries may not protect our intellectual
property rights to the same extent as the laws of the United
States. The loss or infringement of our trademarks or tradenames
could impair the goodwill associated with our brands and harm
our reputation, which would harm our financial condition and
operating results.
Unlike in most of the other markets in which we operate, limited
protection of intellectual property is available under Chinese
law. Accordingly, we face an increased risk in China that
unauthorized parties may attempt to copy or otherwise obtain or
use our trademarks, copyrights, product formulations or other
intellectual property. Further, since Chinese commercial law is
relatively undeveloped, we may have limited legal recourse in
the event we encounter significant difficulties with
intellectual property theft or infringement. As a result, we
cannot assure you that we will be able to adequately protect our
product formulations or other intellectual property.
If our
distributors fail to comply with labeling laws, then our
financial condition and operating results would be
harmed.
Although the physical labeling of our products is not within the
control of our independent distributors, our distributors must
nevertheless advertise our products in compliance with the
extensive regulations that exist in certain jurisdictions, such
as the United States, which considers product advertising to be
labeling for regulatory purposes.
39
Our products are sold principally as foods, dietary supplements
and cosmetics and are subject to rigorous FDA and related legal
regimens limiting the types of therapeutic claims that can be
made for our products. The treatment or cure of disease, for
example, is not a permitted claim for these products. While we
train and attempt to monitor our distributors marketing
materials, we cannot ensure that all such materials comply with
bans on therapeutic claims. If our distributors fail to comply
with these restrictions, then we and our distributors could be
subjected to claims, financial penalties, mandatory product
recalls or relabeling requirements, which could harm our
financial condition and operating results. Although we expect
that our responsibility for the actions of our independent
distributors in such an instance would be dependent on a
determination that we either controlled or condoned a
noncompliant advertising practice, there can be no assurance
that we could not be held responsible for the actions of our
independent distributors.
If our
intellectual property is not adequate to provide us with a
competitive advantage or to prevent competitors from replicating
our products, or if we infringe the intellectual property rights
of others, then our financial condition and operating results
would be harmed.
Our future success and ability to compete depend upon our
ability to timely produce innovative products and product
enhancements that motivate our distributors and customers, which
we attempt to protect under a combination of copyright,
trademark and trade secret laws, confidentiality procedures and
contractual provisions. However, our products are generally not
patented domestically or abroad, and the legal protections
afforded by our common law and contractual proprietary rights in
our products provide only limited protection and may be
time-consuming and expensive to enforce
and/or
maintain. Further, despite our efforts, we may be unable to
prevent third parties from infringing upon or misappropriating
our proprietary rights or from independently developing
non-infringing products that are competitive with, equivalent to
and/or
superior to our products.
Additionally, third parties may claim that products we have
independently developed infringe upon their intellectual
property rights. For example, in two related lawsuits that are
currently pending in California, Unither Pharma, Inc. and others
are alleging that sales by Herbalife International of
(1) its
Niteworkstm
and Prelox Blue products and (2) its former products
Womans Advantage with DHEA and Optimum Performance
infringe on patents that are licensed to or owned by those
parties, and are seeking unspecified damages, attorneys
fees and injunctive relief from the Company. Although we believe
that we have meritorious defenses to, and are vigorously
defending against, these allegations, there can be no assurance
that one or more of our products will not be found to infringe
upon the intellectual property rights of these parties or others.
Monitoring infringement
and/or
misappropriation of intellectual property can be difficult and
expensive, and we may not be able to detect any infringement or
misappropriation of our proprietary rights. Even if we do detect
infringement or misappropriation of our proprietary rights,
litigation to enforce these rights could cause us to divert
financial and other resources away from our business operations.
Further, the laws of some foreign countries do not protect our
proprietary rights to the same extent as do the laws of the
United States.
Since
one of our products constitutes a significant portion of our
retail sales, significant decreases in consumer demand for this
product or our failure to produce a suitable replacement should
we cease offering it would harm our financial condition and
operating results.
Our Formula 1 meal replacement product constitutes a significant
portion of our sales, accounting for approximately 27%, 22%, and
23% of retail sales for the fiscal years ended December 31,
2005, 2004 and 2003, respectively. If consumer demand for this
product decreases significantly or we cease offering this
product without a suitable replacement, then our financial
condition and operating results would be harmed.
If we
lose the services of members of our senior management team, then
our financial condition and operating results would be
harmed.
We depend on the continued services of our Chief Executive
Officer, Michael O. Johnson, and our current senior management
team and the relationships that they have developed with our
senior distributor leadership, especially in light of the high
level of turnover in our former senior management team, and the
resulting need to reestablish good working relationships with
our senior distributor leadership, after the death of our
founder in May
40
of 2000. Although we have entered into employment agreements
with many members of our senior management team, and do not
believe that any of them are planning to leave or retire in the
near term, we cannot assure you that our senior managers will
remain with us. The loss or departure of any member of our
senior management team could negatively impact our distributor
relations and operating results. If any of these executives do
not remain with us, our business could suffer. The loss of such
key personnel could negatively impact our ability to implement
our business strategy, and our continued success will also be
dependent upon our ability to retain existing, and attract
additional, qualified personnel to meet our needs. We currently
do not maintain key person life insurance with
respect to our senior management team.
The
covenants in our existing indebtedness limit our discretion with
respect to certain business matters, which could limit our
ability to pursue certain strategic objectives and in turn harm
our financial condition and operating results.
Our
91/2% Notes
and senior credit facility contain numerous financial and
operating covenants that restrict our and our subsidiaries
ability to, among other things:
|
|
|
|
|
pay dividends, redeem share capital or capital stock and make
other restricted payments and investments;
|
|
|
|
incur additional debt or issue preferred shares;
|
|
|
|
allow the imposition of dividend or other distribution
restrictions on our subsidiaries;
|
|
|
|
create liens on our and our subsidiaries assets;
|
|
|
|
engage in transactions with affiliates;
|
|
|
|
guarantee other indebtedness; and
|
|
|
|
merge, consolidate or sell all or substantially all of our
assets and the assets of our subsidiaries.
|
In addition, our senior credit facility requires us to meet
certain financial ratios and financial conditions. Our ability
to comply with these covenants may be affected by events beyond
our control, including prevailing economic, financial and
industry conditions. Failure to comply with these covenants
could result in a default causing all amounts to become due and
payable under our outstanding notes
and/or the
senior credit facility, which is secured by substantially all of
our assets, which the lenders thereunder could proceed to
foreclose against.
If we
do not comply with transfer pricing and similar tax regulations,
then we may be subjected to additional taxes, interest and
penalties in material amounts, which could harm our financial
condition and operating results.
As a multinational corporation, in many countries including the
United States, we are subject to transfer pricing and other tax
regulations designed to ensure that our intercompany
transactions are consummated at prices that have not been
manipulated to produce a desired tax result, that appropriate
levels of income are reported as earned by our United States or
local entities, and that we are taxed appropriately on such
transactions. In addition, our operations are subject to
regulations designed to ensure that appropriate levels of
customs duties are assessed on the importation of our products.
We are currently subject to pending or proposed audits that are
at various levels of review, assessment or appeal in a number of
jurisdictions involving transfer pricing issues, income taxes,
customs duties, value added taxes, withholding taxes, sales and
use and other taxes and related interest and penalties in
material amounts. In some circumstances, additional taxes,
interest and penalties have been assessed and we will be
required to pay the assessments or litigate to reverse the
assessments. We have reserved in the consolidated financial
statements an amount that we believe represents the most likely
outcome of the resolution of these disputes, but if we are
incorrect in our assessment we may have to pay the full amount
asserted. Ultimate resolution of these matters may take several
years, and the outcome is uncertain. If the United States
Internal Revenue Service or the taxing authorities of any other
jurisdiction were to successfully challenge our transfer pricing
practices, we could become subject to higher taxes and our
earnings would be adversely affected.
41
We may
be held responsible for certain taxes or assessments relating to
the activities of our distributors, which could harm our
financial condition and operating results.
Our distributors are subject to taxation, and in some instances,
legislation or governmental agencies impose an obligation on us
to collect taxes, such as value added taxes, and to maintain
appropriate records. In addition, we are subject to the risk in
some jurisdictions of being responsible for social security and
similar taxes with respect to our distributors. In the event
that local laws and regulations or the interpretation of local
laws and regulations change to require us to treat our
independent distributors as employees, or that our distributors
are deemed by local regulatory authorities in one or more of the
jurisdictions in which we operate to be our employees rather
than independent contractors under existing laws and
interpretations, we may be held responsible for social security
and related taxes in those jurisdictions, plus any related
assessments and penalties, which could harm our financial
condition and operating results.
We may
incur material product liability claims, which could increase
our costs and harm our financial condition and operating
results.
Our products consist of herbs, vitamins and minerals and other
ingredients that are classified as foods or dietary supplements
and are not subject to pre-market regulatory approval in the
United States. Our products could contain contaminated
substances, and some of our products contain innovative
ingredients that do not have long histories of human
consumption. We generally do not conduct or sponsor clinical
studies for our products and previously unknown adverse
reactions resulting from human consumption of these ingredients
could occur. As a marketer of dietary and nutritional
supplements and other products that are ingested by consumers or
applied to their bodies, we have been, and may again be,
subjected to various product liability claims, including that
the products contain contaminants, the products include
inadequate instructions as to their uses, or the products
include inadequate warnings concerning side effects and
interactions with other substances. It is possible that
widespread product liability claims could increase our costs,
and adversely affect our revenues and operating income.
Moreover, liability claims arising from a serious adverse event
may increase our costs through higher insurance premiums and
deductibles, and may make it more difficult to secure adequate
insurance coverage in the future. In addition, our product
liability insurance may fail to cover future product liability
claims, thereby requiring us to pay substantial monetary damages
and adversely affecting our business. Finally, given the higher
level of self-insured retentions that we have accepted under our
current product liability insurance policies, which are as high
as approximately $10 million, in certain cases we may be
subject to the full amount of liability associated with any
injuries, which could be substantial.
Several years ago, a number of states restricted the sale of
dietary supplements containing botanical sources of ephedrine
alkaloids and on February 6, 2004, the FDA banned the use
of such ephedrine alkaloids. Until late 2002, we had sold
Thermojetics®
original green herbal tablets,
Thermojetics®
green herbal tablets and
Thermojetics®
gold herbal tablets, all of which contained ephedrine alkaloids.
Accordingly, we run the risk of product liability claims related
to the ingestion of ephedrine alkaloids contained in those
products. Currently, we have been named as a defendant in
product liability lawsuits seeking to link the ingestion of
certain of the aforementioned products to subsequent alleged
medical problems suffered by plaintiffs. Although we believe
that we have meritorious defenses to the allegations contained
in these lawsuits, and are vigorously defending these claims,
there can be no assurance that we will prevail in our defense of
any or all of these matters.
A few
of our shareholders collectively exert significant influence
over us and have the power to cause the approval or rejection of
all shareholder actions and may take actions that conflict with
your interests.
As of February 1, 2006, affiliates of Whitney and Golden
Gate Capital own approximately 41.5% of the voting power of our
share capital. Accordingly, the Equity Sponsors collectively
will have the power to exert significant influence over us and
the approval or rejection of any matter on which the
shareholders may vote, including the election of directors,
amendment of our memorandum and articles of association and
approval of significant corporate transactions and they will
have significant control over our management and policies. This
influence over corporate actions may also delay, deter or
prevent transactions that would result in a change of control.
Moreover, the Equity Sponsors may have interests that conflict
with yours.
42
We are
subject to, among other things, the attestation requirements
regarding the effectiveness of internal control over financial
reporting. These requirements have increased our compliance
costs, and failure to comply in a timely manner could adversely
affect the value of our securities.
We are required to comply with various corporate governance and
financial reporting requirements under the Sarbanes-Oxley Act of
2002, as well as new rules and regulations adopted by the
Commission, the Public Company Accounting Oversight Board and
the NYSE. In particular, we are required to include management
and auditor reports on the effectiveness of internal control
over financial reporting as part of our annual report on
Form 10-K
for the year ended December 31, 2006, pursuant to
Section 404 of the Sarbanes-Oxley Act. We expect to
continue to spend significant amounts of time and money on
compliance with these rules. Our failure to correct any noted
weaknesses in internal controls over financial reporting could
result in the disclosure of material weaknesses which could have
a material adverse effect upon the market value of our stock.
Holders
of our common shares may face difficulties in protecting their
interests because we are incorporated under Cayman Islands
law.
Our corporate affairs are governed by our amended and restated
memorandum and articles of association, by the Companies Law
(2004 Revision) and the common law of the Cayman Islands. The
rights of our shareholders and the fiduciary responsibilities of
our directors under Cayman Islands law are not as clearly
established as under statutes or judicial precedent in existence
in jurisdictions in the United States. Therefore, shareholders
may have more difficulty in protecting their interests in the
face of actions by our management, directors or controlling
shareholders than would shareholders of a corporation
incorporated in a jurisdiction in the United States, due to the
comparatively less developed nature of Cayman Islands law in
this area.
Unlike many jurisdictions in the United States, Cayman Islands
law does not specifically provide for shareholder appraisal
rights on a merger or consolidation of a company. This may make
it more difficult for shareholders to assess the value of any
consideration they may receive in a merger or consolidation or
to require that the offer give shareholders additional
consideration if they believe the consideration offered is
insufficient.
Shareholders of Cayman Islands exempted companies such as
ourselves have no general rights under Cayman Islands law to
inspect corporate records and accounts or to obtain copies of
lists of our shareholders. Our directors have discretion under
our articles of association to determine whether or not, and
under what conditions, our corporate records may be inspected by
our shareholders, but are not obliged to make them available to
our shareholders. This may make it more difficult for you to
obtain the information needed to establish any facts necessary
for a shareholder motion or to solicit proxies from other
shareholders in connection with a proxy contest.
Subject to limited exceptions, under Cayman Islands law, a
minority shareholder may not bring a derivative action against
the board of directors. Maples and Calder, our Cayman Islands
counsel, has informed us that they are not aware of any reported
class action or derivative action having been brought in a
Cayman Islands court.
Provisions
of our articles of association and Cayman Islands corporate law
may impede a takeover or make it more difficult for shareholders
to change the direction or management of the Company, which
could adversely affect the value of our common shares and
provide shareholders with less input into the management of the
Company than they might otherwise have.
Our articles of association permit our board of directors to
issue preference shares from time to time, with such rights and
preferences as they consider appropriate. Our board of directors
could authorize the issuance of preference shares with terms and
conditions and under circumstances that could have an effect of
discouraging a takeover or other transaction.
In addition, our articles of association contain certain other
provisions which could have an effect of discouraging a takeover
or other transaction or preventing or making it more difficult
for shareholders to change the direction or management of our
Company, including a classified board, the inability of
shareholders to act by written consent, a limitation on the
ability of shareholders to call special meetings of shareholders
and advance notice provisions. As a result, our shareholders may
have less input into the management of our Company than they
might otherwise have if these provisions were not included in
our articles of association.
43
Unlike many jurisdictions in the United States, Cayman Islands
law does not provide for mergers as that expression is
understood under corporate law in the United States. However,
Cayman Islands law does have statutory provisions that provide
for the reconstruction and amalgamation of companies, which are
commonly referred to in the Cayman Islands as schemes of
arrangement. The procedural and legal requirements
necessary to consummate these transactions are more rigorous and
take longer to complete than the procedures typically required
to consummate a merger in the United States. Under Cayman
Islands law and practice, a scheme of arrangement in relation to
a solvent Cayman Islands company must be approved at a
shareholders meeting by each class of shareholders, in
each case, by a majority of the number of holders of each class
of a companys shares that are present and voting (either
in person or by proxy) at such a meeting, which holders must
also represent 75% in value of such class issued that are
present and voting (either in person or by proxy) at such
meeting (excluding the shares owned by the parties to the scheme
of arrangement).
The convening of these meetings and the terms of the
amalgamation must also be sanctioned by the Grand Court of the
Cayman Islands. Although there is no requirement to seek the
consent of the creditors of the parties involved in the scheme
of arrangement, the Grand Court typically seeks to ensure that
the creditors have consented to the transfer of their
liabilities to the surviving entity or that the scheme of
arrangement does not otherwise have a material adverse effect on
the creditors interests. Furthermore, the Grand Court will
only approve a scheme of arrangement if it is satisfied that:
|
|
|
|
|
the statutory provisions as to majority vote have been complied
with;
|
|
|
|
the shareholders have been fairly represented at the meeting in
question;
|
|
|
|
the scheme of arrangement is such as a businessman would
reasonably approve; and
|
|
|
|
the scheme or arrangement is not one that would more properly be
sanctioned under some other provision of the Companies Law.
|
There
is uncertainty as to shareholders ability to enforce
certain foreign civil liabilities in the Cayman
Islands.
We are incorporated as an exempted company with limited
liability under the laws of the Cayman Islands. A material
portion of our assets are located outside of the United States.
As a result, it may be difficult for our shareholders to enforce
judgments against us or judgments obtained in U.S. courts
predicated upon the civil liability provisions of the federal
securities laws of the United States or any state of the United
States.
We have been advised by our Cayman Islands counsel, Maples and
Calder, that although there is no statutory enforcement in the
Cayman Islands of judgments obtained in the United States, the
courts of the Cayman Islands will based on the
principle that a judgment by a competent foreign court imposes
upon the judgment debtor an obligation to pay the sum for which
judgment has been given recognize and enforce a
foreign judgment of a court of competent jurisdiction if such
judgment is final, for a liquidated sum, not in respect of taxes
or a fine or penalty, is not inconsistent with a Cayman Islands
judgment in respect of the same matters, and was not obtained in
a manner, and is not of a kind, the enforcement of which is
contrary to the public policy of the Cayman Islands. There is
doubt, however, as to whether the Grand Court of the Cayman
Islands will (a) recognize or enforce judgments of
U.S. courts predicated upon the civil liability provisions
of the federal securities laws of the United States or any
state of the United States, or (b) in original actions
brought in the Cayman Islands, impose liabilities predicated
upon the civil liability provisions of the federal securities
laws of the United States or any state of the United States, on
the grounds that such provisions are penal in nature.
The Grand Court of the Cayman Islands may stay proceedings if
concurrent proceedings are being brought elsewhere.
|
|
Item 2.
|
UNREGISTERED
SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
|
None.
44
|
|
Item 3.
|
DEFAULTS
UPON SENIOR SECURITIES
|
None.
|
|
Item 4.
|
SUBMISSION
OF MATTERS TO A VOTE OF SECURITY HOLDERS
|
None.
|
|
Item 5.
|
OTHER
INFORMATION
|
(a) None.
(b) None.
(a) Exhibit Index:
45
EXHIBIT INDEX
|
|
|
|
|
|
|
Exhibit
|
|
|
|
|
Number
|
|
Description
|
|
Reference
|
|
|
2
|
.1
|
|
Agreement and Plan of Merger,
dated April 10, 2002, by and among Herbalife International,
Inc., WH Holdings (Cayman Islands) Ltd. and WH Acquisition Corp.
|
|
(a)
|
|
3
|
.1
|
|
Form of Amended and Restated
Memorandum and Articles of Association of Herbalife Ltd.
|
|
(d)
|
|
4
|
.1
|
|
Indenture, dated as of
June 27, 2002 between WH Acquisition Corp., WH Intermediate
Holdings Ltd., WH Luxembourg Holdings SàRL, WH Luxembourg
Intermediate Holdings SàRL, WH Luxembourg CM SàRL and
The Bank of New York as Trustee governing
113/4% Senior
Subordinated Notes due 2010
|
|
(a)
|
|
4
|
.2
|
|
Indenture, dated as of
March 8, 2004 between WH Holdings (Cayman Islands) Ltd., WH
Capital Corporation and The Bank of New York as trustee
governing
91/2% Notes
due 2011
|
|
(a)
|
|
4
|
.3
|
|
Form of Share Certificate
|
|
(d)
|
|
9
|
.1
|
|
Shareholders Agreement dated
as of July 31, 2002, by and among WH Holdings (Cayman
Islands) Ltd., Whitney V, L.P., Whitney Strategic
Partners V, L.P., WH Investments Ltd., CCG Investments
(BVI), L.P., CCG Associates-QP, LLC, CCG Associates-AI, LLC, CCG
Investment Fund-AI, L.P., CCG AV, LLC-Series C, CCG AV,
LLC-Series E, and certain other persons
|
|
(a)
|
|
9
|
.2
|
|
Voting Agreement, dated as of
December 31, 2004 by and among Whitney V, L.P.,
Whitney Strategic Partners V, L.P., Whitney Private Debt
Fund, L.P. and Green River Offshore Fund, Ltd., on the one hand,
and CCG Investments (BVI), L.P., CCG Associates-QP, LLC, CCG
Associates-AI, LLC, CCG Investment Fund-AI, LP, CCG AV,
LLC-Series C, CCG AV,
LLC-Series E
and CCG CI, LLC on the other hand
|
|
(f)
|
|
10
|
.1
|
|
Form of Indemnity Agreement
between Herbalife International Inc. and certain officers and
directors of Herbalife International Inc.
|
|
(a)
|
|
10
|
.2
|
|
Office lease agreement between
Herbalife International of America Inc. and State Teachers
Retirement System, dated July 11, 1995
|
|
(a)
|
|
10
|
.3#
|
|
Herbalife International of
America, Inc.s Senior Executive Deferred Compensation
Plan, effectivex January 1, 1996, as amended
|
|
(a)
|
|
10
|
.4#
|
|
Herbalife International of
America, Inc.s Management Deferred Compensation Plan,
effective January 1, 1996, as amended
|
|
(a)
|
|
10
|
.5
|
|
Master Trust Agreement
between Herbalife International of America, Inc. and Imperial
Trust Company, Inc., effective January 1, 1996
|
|
(a)
|
|
10
|
.6#
|
|
Herbalife International Inc. 401K
Profit Sharing Plan and Trust, as amended
|
|
(a)
|
|
10
|
.7
|
|
Trust Agreement for Herbalife
2001 Executive Retention Plan, effective March 15, 2001
|
|
(a)
|
|
10
|
.8#
|
|
Herbalife 2001 Executive Retention
Plan, effective March 15, 2001
|
|
(a)
|
|
10
|
.9#
|
|
Separation Agreement and General
Release, dated as of May 17, 2002, between
Robert Sandler and Herbalife International, Inc. and
Herbalife International of America, Inc. and Clarification
|
|
(a)
|
|
10
|
.10
|
|
Agreement for Retention of Legal
Services, dated as of May 20, 2002, by and among Herbalife
International, Inc., Herbalife International of America, Inc.
and Robert A. Sandler
|
|
(a)
|
|
10
|
.11
|
|
Purchase Agreement, dated as of
June 21, 2002, by and among WH Acquisition Corp., Herbalife
International, Inc., WH Intermediate Holdings Ltd., WH
Luxembourg Holdings SàRL, WH Luxembourg Intermediate
Holdings SàRL, WH Luxembourg CM SàRL and UBS Warburg
LLC
|
|
(a)
|
|
10
|
.12
|
|
Registration Rights Agreement,
dated as of June 27, 2002, by and among WH Acquisition
Corp., WH Intermediate Holdings Ltd., WH Luxembourg Holdings
SàRL, WH Luxembourg Intermediate Holdings SàRL, WH
Luxembourg CM SàRL and UBS Warburg LLC
|
|
(a)
|
46
|
|
|
|
|
|
|
Exhibit
|
|
|
|
|
Number
|
|
Description
|
|
Reference
|
|
|
10
|
.13
|
|
Notice to Distributors regarding
Amendment to Agreements of Distributorship, dated as of
July 18, 2002 between Herbalife International, Inc. and
each Herbalife Distributor
|
|
(a)
|
|
10
|
.14
|
|
Indemnity Agreement dated as of
July 31, 2002, by and among WH Holdings (Cayman Islands)
Ltd., WH Acquisition Corp., Whitney & Co., LLC,
Whitney V, L.P., Whitney Strategic Partners V, L.P.,
GGC Administration, L.L.C., Golden Gate Private Equity, Inc.,
CCG Investments (BVI), L.P., CCG Associates-AI, LLC, CCG
Investment Fund-AI, LP, CCG AV, LLC-Series C, CCG AV,
LLC-Series C, CCG AV, LLC-Series E, CCG Associates-QP,
LLC and WH Investments Ltd.
|
|
(a)
|
|
10
|
.15#
|
|
Independent Directors Stock
Option Plan of WH Holdings (Cayman Islands) Ltd.
|
|
(a)
|
|
10
|
.16#
|
|
Employment Agreement, dated as of
March 10, 2003 between Brian Kane and Herbalife
International, Inc. and Herbalife International of America, Inc.
|
|
(a)
|
|
10
|
.17#
|
|
Employment Agreement dated as of
March 10, 2003 between Carol Hannah and Herbalife
International, Inc. and Herbalife International of America, Inc.
|
|
(a)
|
|
10
|
.18#
|
|
Non-Statutory Stock Option
Agreement, dated as of March 10, 2003 between WH Holdings
(Cayman Islands) Ltd. and Brian Kane
|
|
(a)
|
|
10
|
.19#
|
|
Non-Statutory Stock Option
Agreement, dated as of March 10, 2003 between WH Holdings
(Cayman Islands) Ltd. and Carol Hannah
|
|
(a)
|
|
10
|
.20#
|
|
WH Holdings (Cayman Islands) Ltd.
Stock Incentive Plan, as restated, dated as of November 5,
2003
|
|
(a)
|
|
10
|
.21#
|
|
Side Letter Agreement dated as of
March 10, 2003 by and among WH Holdings (Cayman Islands)
Ltd., Brian Kane and Carol Hannah and the Shareholders listed
therein
|
|
(a)
|
|
10
|
.22#
|
|
Employment Agreement dated as of
April 3, 2003 between Michael O. Johnson and Herbalife
International, Inc. and Herbalife International of America, Inc.
|
|
(a)
|
|
10
|
.23#
|
|
Non-Statutory Stock Option
Agreement, dated as of April 3, 2003 between WH Holdings
(Cayman Islands) Ltd. and Michael O. Johnson
|
|
(a)
|
|
10
|
.24#
|
|
Side Letter Agreement dated as of
April 3, 2003 by and among WH Holdings (Cayman Islands)
Ltd., Michael O. Johnson and the Shareholders listed therein
|
|
(a)
|
|
10
|
.25#
|
|
Employment Agreement dated as of
July 14, 2003 between Matt Wisk and Herbalife International
of America, Inc.
|
|
(a)
|
|
10
|
.26#
|
|
Employment Agreement dated as of
July 31, 2003 between Gregory L. Probert and Herbalife
International of America, Inc.
|
|
(a)
|
|
10
|
.27#
|
|
Employment Agreement dated
October 6, 2003 between Brett R. Chapman and Herbalife
International of America, Inc.
|
|
(a)
|
|
10
|
.28#
|
|
Form of Non-Statutory Stock Option
Agreement (Non-Executive Agreement)
|
|
(a)
|
|
10
|
.29#
|
|
Form of Non-Statutory Stock Option
Agreement (Executive Agreement)
|
|
(a)
|
|
10
|
.30
|
|
Registration Rights Agreement,
dated as of March 8, 2004, by and among WH Holdings (Cayman
Islands) Ltd., WH Capital Corporation and UBS Securities, LLC
|
|
(a)
|
|
10
|
.31
|
|
Indemnity Agreement, dated as of
February 9, 2004, among WH Capital Corporation and Gregory
Probert
|
|
(a)
|
|
10
|
.32
|
|
Indemnity Agreement, dated as of
February 9, 2004, among WH Capital Corporation and
Brett R. Chapman
|
|
(a)
|
|
10
|
.33
|
|
Stock Subscription Agreement of WH
Capital Corporation, dated as of February 9, 2004, between
WH Capital Corporation and WH Holdings (Cayman Islands) Ltd.
|
|
(a)
|
|
10
|
.34
|
|
First Amendment to Amended and
Restated WH Holdings (Cayman Islands) Ltd. Stock Incentive Plan,
dated November 5, 2003
|
|
(a)
|
47
|
|
|
|
|
|
|
Exhibit
|
|
|
|
|
Number
|
|
Description
|
|
Reference
|
|
|
10
|
.35#
|
|
Separation Agreement and General
Release dated May 1, 2004, among Herbalife International,
Inc., Herbalife International of America, Inc. and Carol Hannah
|
|
(a)
|
|
10
|
.36#
|
|
Consulting Agreement dated
May 1, 2004 among Herbalife International of America, Inc.
and Carol Hannah
|
|
(a)
|
|
10
|
.37#
|
|
Employment Agreement dated
June 1, 2004 among Herbalife International of America, Inc.
and Richard Goudis
|
|
(a)
|
|
10
|
.38
|
|
Purchase Agreement, dated
March 3, 2004, by and among WH Holdings (Cayman Islands)
Ltd., WH Capital Corporation and UBS Securities LLC
|
|
(a)
|
|
10
|
.39
|
|
Registration Rights Agreement,
dated as of July 31, 2002, by and among WH Holdings (Cayman
Islands) Ltd., Whitney V, L.P., Whitney Strategic
Partners V, L.P., WH Investments Ltd., CCG Investments
(BVI), L.P., CCG Associates-QP, LLC, CCG Associates-AI, LLC, CCG
Investment Fund-AI, L.P., CCG AV, LLC-Series C and CCG AV,
LLC-Series E.
|
|
(b)
|
|
10
|
.40
|
|
Share Purchase Agreement, dated as
of July 31, 2002, by and among WH Holdings (Cayman Islands)
Ltd., Whitney Strategic Partners V, L.P., WH Investments
Ltd., Whitney V, L.P., CCG Investments (BVI), L.P., CCG
Associates-QP, LLC, CCG Associates-AI, LLC, CCG Investment
Fund-AI, LP, CCG AV, LLC-Series C and CCG AV,
LLC-Series E.
|
|
(b)
|
|
10
|
.41
|
|
Form of Indemnification Agreement
between Herbalife Ltd. and the directors and certain officers of
Herbalife Ltd.
|
|
(c)
|
|
10
|
.42#
|
|
Herbalife Ltd. 2004 Stock
Incentive Plan, effective December 1, 2004
|
|
(c)
|
|
10
|
.43
|
|
Termination Agreement, dated as of
December 1, 2004, between Herbalife Ltd., Herbalife
International, Inc. and Whitney & Co., LLC.
|
|
(d)
|
|
10
|
.44
|
|
Termination Agreement, dated as of
December 1, 2004, between Herbalife Ltd., Herbalife
International Inc. and GGC Administration, L.L.C.
|
|
(d)
|
|
10
|
.45
|
|
Termination Agreement, dated as of
December 13, 2004, by and among Herbalife Ltd.,
Whitney V, L.P., Whitney Strategic Partners V, L.P.,
CCG Investments (BVI), L.P., CCG Associates-QP, LLC, CCG
Associates-AI, LLC, CCG Investment Fund-AI, LP, CCG AV,
LLC-Series C, CCG AV, LLC-Series E and CCG CI, LLC.
|
|
(d)
|
|
10
|
.46
|
|
Indemnification Agreement, dated
as of December 13, 2004, by and among Herbalife Ltd.,
Herbalife International, Inc., Whitney V, L.P., Whitney
Strategic Partners V, L.P., CCG Investments (BVI), L.P.,
CCG Associates-QP, LLC, CCG Associates-AI, LLC, CCG Investment
Fund-AI, LP, CCG AV, LLC-Series C, CCG AV,
LLC-Series E, CCG CI, LLC and GGC Administration, LLC.
|
|
(d)
|
|
10
|
.47#
|
|
Amendment No. 1 to Herbalife
Ltd. 2004 Stock Incentive Plan
|
|
(e)
|
|
10
|
.48#
|
|
Form of Stock Bonus Award Agreement
|
|
(e)
|
|
10
|
.49#
|
|
Contract for Services of a
Consultant between Herbalife International Luxembourg
S.á.R.L. and Brian Kane dated as of October 18, 2004
|
|
(f)
|
|
10
|
.50#
|
|
Compromise Agreement between
Herbalife International Luxembourg S.á.R.L. and Brian Kane
dated as of October 18, 2004
|
|
(f)
|
|
10
|
.51
|
|
Credit Agreement, dated as of
December 21, 2004, by and among Herbalife International
Inc., Herbalife Ltd., WH Intermediate Holdings Ltd., HBL Ltd.,
WH Luxembourg Holdings S.á.R.L., HLF Luxembourg Holdings,
S.á.R.L., WH Capital Corporation, WH Luxembourg
Intermediate Holdings S.á.R.L. and the Subsidiary
Guarantors party hereto, and certain lenders and agents named
therein.
|
|
(g)
|
48
|
|
|
|
|
|
|
Exhibit
|
|
|
|
|
Number
|
|
Description
|
|
Reference
|
|
|
10
|
.52
|
|
Security Agreement, dated as of
December 21, 2004, by and among Herbalife International,
Inc., Herbalife Ltd., WH Intermediate Holdings Ltd., HBL Ltd.,
WH Luxembourg Holdings S.á.R.L., HLF Luxembourg Holdings,
S.á.R.L., WH Capital Corporation, WH Luxembourg
Intermediate Holdings S.á.R.L., and the Subsidiary
Guarantors party thereto in favor of Morgan Stanley &
Co. Incorporated, as Collateral Agent.
|
|
(g)
|
|
10
|
.53
|
|
First Amendment to Credit
Agreement, dated as of April 12, 2005, by and among
Herbalife International Inc., Herbalife Ltd., WH Intermediate
Holdings Ltd., HBL Ltd., WH Luxembourg Holdings S.á.R.L.,
HLF Luxembourg Holdings, S.á.R.L., WH Capital Corporation,
WH Luxembourg Intermediate Holdings S.á.R.L. and the
Subsidiary Guarantors party thereto, and certain lenders and
agents named therein.
|
|
(g)
|
|
10
|
.54#
|
|
Employment Agreement Effective as
of January 1, 2005 between Herbalife Ltd. and
Henry Burdick
|
|
(h)
|
|
10
|
.55#
|
|
Form of 2004 Herbalife Ltd. 2004
Stock Incentive Plan Stock Option Agreement
|
|
(i)
|
|
10
|
.56#
|
|
Form of 2004 Herbalife Ltd. 2004
Stock Incentive Plan Non-Employee Director Stock Option Agreement
|
|
(i)
|
|
10
|
.57
|
|
Second Amendment to Credit
Agreement, dated as of August 19, 2005, by and among
Herbalife International, Inc., Herbalife Ltd., WH Intermediate
Holdings Ltd., HBL Ltd., WH Luxembourg Holdings S.á.R.L.,
HLF Luxembourg Holdings, S.á.R.L., WH Capital Corporation,
WH Luxembourg Intermediate Holdings S.á.R.L. and the
Subsidiary Guarantors party thereto, and certain lenders and
agents named therein.
|
|
(k)
|
|
10
|
.58
|
|
Service Agreement by and between
Herbalife Europe Limited and Wynne Roberts ESQ, dated as of
September 6, 2005.
|
|
(l)
|
|
10
|
.59#
|
|
Amendment to employment agreement
between Michael O. Johnson and Herbalife International, Inc. and
Herbalife International of America, Inc., dated May 15,
2005.
|
|
(m)
|
|
10
|
.60#
|
|
Herbalife Ltd. Independent
Directors Deferred Compensation and Stock Unit Plan
|
|
(n)
|
|
10
|
.61#
|
|
Herbalife Ltd. Independent
Directors Deferred Compensation and Stock Unit Plan Independent
Directors Stock Unit Award Agreement
|
|
(n)
|
|
10
|
.62#
|
|
Form of Herbalife Ltd. 2005 Stock
Incentive Plan Stock Unit Award Agreement
|
|
(o)
|
|
10
|
.63#
|
|
Form of Herbalife Ltd. 2005 Stock
Incentive Plan Stock Appreciation Right Award Agreement
|
|
(o)
|
|
10
|
.64#
|
|
Form of Herbalife Ltd. 2005 Stock
Incentive Plan Stock Unit Award Agreement applicable to Mr.
Michael O. Johnson
|
|
(p)
|
|
10
|
.64#
|
|
Form of Herbalife Ltd. 2005 Stock
Incentive Plan Stock Appreciation Right Award Agreement
applicable to Mr. Michael O. Johnson
|
|
(p)
|
|
10
|
.65#
|
|
Amendment to Herbalife Ltd.
Independent Directors Deferred Compensation and Stock Unit Plan
|
|
(q)
|
|
10
|
.66#
|
|
Form of Herbalife Ltd. 2005 Stock
Incentive Plan Stock Unit Award Agreement applicable to Messrs.
Gregory Probert, Brett R. Chapman and Richard Goudis
|
|
(r)
|
|
10
|
.67#
|
|
Form of Herbalife Ltd. 2005 Stock
Incentive Plan Stock Appreciation Right Award Agreement
applicable to Messrs. Gregory Probert, Brett R. Chapman and
Richard Goudis
|
|
(r)
|
|
10
|
.68#
|
|
Amended and restated employment
agreement effective April 17, 2006 between Herbalife
International of America, Inc. and Paul Noack
|
|
*
|
|
31
|
.1
|
|
Rule 13a-14(a)
Certification of Chief Executive Officer
|
|
*
|
|
31
|
.2
|
|
Rule 13a-14(a)
Certification of Chief Financial Officer
|
|
*
|
|
32
|
.1
|
|
Section 1350 Certification of
Chief Executive Officer and Chief Financial Officer
|
|
*
|
49
|
|
|
|
|
|
|
Exhibit
|
|
|
|
|
Number
|
|
Description
|
|
Reference
|
|
|
99
|
.1
|
|
Disposition Agreement dated as of
December 13, 2004 is by and among Whitney V, L.P., a
Delaware limited partnership, Whitney Strategic Partners V,
L.P., a Delaware limited partnership, Whitney Private Debt Fund,
L.P., a Delaware limited partnership and Green River Offshore
Fund, Ltd., a Cayman Islands company on the one hand, and CCG
Investments (BVI), L.P., a British Virgin Islands limited
partnership, CCG Associates-QP, LLC, a Delaware limited
liability company, CCG Associates-AI, LLC, a Delaware limited
liability company, CCG Investment Fund-AI, LP, a Delaware
limited partnership, CCG AV, LLC-Series C, a Delaware
limited liability company, CCG AV, LLC-Series E, a Delaware
limited liability company and CCG CI, LLC a Delaware limited
liability company on the other hand.
|
|
(d)
|
|
|
|
* |
|
Filed herewith. |
|
# |
|
Management contract or compensatory plan or arrangement. |
|
(a) |
|
Previously filed on October 1, 2004 as an Exhibit to the
Companys registration statement on
Form S-1
(File
No. 333-119485)
and is incorporated herein by reference. |
|
(b) |
|
Previously filed on November 9, 2004 as an Exhibit to
Amendment No. 2 to the Companys registration
statement on
Form S-1
(File
No. 333-119485)
and is incorporated herein by reference. |
|
(c) |
|
Previously filed on December 2, 2004 as an Exhibit to
Amendment No. 4 to the Companys registration
statement on
Form S-1
(File
No. 333-119485)
and is incorporated herein by reference. |
|
(d) |
|
Previously filed on December 14, 2004 as an Exhibit to
Amendment No. 5 to the Companys registration
statement on Form
S-1 (File
No. 333-119485)
and is incorporated herein by reference. |
|
(e) |
|
Previously filed on February 17, 2005 as an Exhibit to the
Companys registration statement on
Form S-8
(File
No. 333-122871)
and is incorporated herein by reference. |
|
(f) |
|
Previously filed on March 14, 2005 as an Exhibit to the
Companys Annual Report on
Form 10-K
for the year ended December 31, 2004 and is incorporated
herein by reference. |
|
(g) |
|
Previously filed on May 9, 2005 as an Exhibit to the
Companys Quarterly Report on
Form 10-Q
for the quarter ended March 31, 2005 and is incorporated
herein by reference. |
|
(h) |
|
Previously filed on May 13, 2005 as an Exhibit to the
Companys Current Report on
Form 8-K
and is incorporated herein by reference. |
|
(i) |
|
Previously filed on June 14, 2005 as an Exhibit to the
Companys Current Report on
Form 8-K
and is incorporated herein by reference. |
|
(k) |
|
Previously filed on August 23, 2005 as an Exhibit to the
Companys Current Report on
Form 8-K
and is incorporated herein by reference. |
|
(l) |
|
Previously filed on September 23, 2005 as an Exhibit to the
Companys Current Report on
Form 8-K
and is incorporated herein by reference. |
|
(m) |
|
Previously filed on August 3, 2005 as an Exhibit to the
Companys current Report on Form 10Q for the quarter
ended June 30, 2005 and is incorporated herein by reference. |
|
(n) |
|
Previously filed on February 28, 2006 as an Exhibit to the
Companys Annual Report on
Form 10-K
for the year ended December 31, 2005 and is incorporated
herein by reference. |
|
(o) |
|
Previously filed on March 29, 2006 as an Exhibit to the
Companys Current Report on Form 8-K. |
|
(p) |
|
Previously filed on March 29, 2006 as an Exhibit to the
Companys Current Report on Form 8-K. |
|
(q) |
|
Previously filed on March 30, 2006 as an Exhibit to the
Companys Current Report on Form 8-K. |
|
(r) |
|
Previously filed on March 31, 2006 as an Exhibit to the
Companys Current Report on Form 8-K. |
50
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the Registrant has duly caused this report to be signed on
its behalf by the undersigned, thereunto duly authorized.
HERBALIFE LTD.
(Registrant)
Richard Goudis
Chief Financial Officer
Date: May 3, 2006
51